{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:51:59Z","timestamp":1790175119935,"version":"4.1.0"},"publisher-location":"Cham","reference-count":348,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030506209","type":"print"},{"value":"9783030506216","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-50621-6_7","type":"book-chapter","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T12:02:40Z","timestamp":1599480160000},"page":"137-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Druggable Lysophospholipid Signaling Pathways"],"prefix":"10.1007","author":[{"given":"Keisuke","family":"Yanagida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Valentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,8]]},"reference":[{"key":"7_CR1","first-page":"134","volume":"240","author":"W Vogt","year":"1960","unstructured":"Vogt W (1960) Intestine-stimulating activity of various phosphatides and glycolipids. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 240:134\u2013139","journal-title":"Naunyn Schmiedebergs Arch Exp Pathol Pharmakol"},{"key":"7_CR2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/BF02533598","volume":"13","author":"A Tokumura","year":"1978","unstructured":"Tokumura A, Fukuzawa K, Tsukatani H (1978) Effects of synthetic and natural lysophosphatidic acids on the arterial blood pressure of different animal species. Lipids 13:572\u2013574","journal-title":"Lipids"},{"key":"7_CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0092-8674(89)90868-4","volume":"59","author":"EJ van Corven","year":"1989","unstructured":"van Corven EJ, Groenink A, Jalink K, Eichholtz T, Moolenaar WH (1989) Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell 59:45\u201354","journal-title":"Cell"},{"key":"7_CR4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1083\/jcb.135.4.1071","volume":"135","author":"JH Hecht","year":"1996","unstructured":"Hecht JH, Weiner JA, Post SR, Chun J (1996) Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J Cell Biol 135:1071\u20131083","journal-title":"J Cell Biol"},{"key":"7_CR5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbalip.2012.08.003","volume":"1831","author":"K Yanagida","year":"2013","unstructured":"Yanagida K, Kurikawa Y, Shimizu T, Ishii S (2013) Current progress in non-Edg family LPA receptor research. Biochim Biophys Acta 1831:33\u201341","journal-title":"Biochim Biophys Acta"},{"key":"7_CR6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-5793(00)01827-5","volume":"478","author":"K Bandoh","year":"2000","unstructured":"Bandoh K, Aoki J, Taira A, Tsujimoto M, Arai H, Inoue K (2000) Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors. FEBS Lett 478:159\u2013165","journal-title":"FEBS Lett"},{"key":"7_CR7","doi-asserted-by":"crossref","first-page":"17731","DOI":"10.1074\/jbc.M808506200","volume":"284","author":"K Yanagida","year":"2009","unstructured":"Yanagida K, Masago K, Nakanishi H, Kihara Y, Hamano F, Tajima Y, Taguchi R, Shimizu T, Ishii S (2009) Identification and characterization of a novel lysophosphatidic acid receptor, p2y5\/LPA6. J Biol Chem 284:17731\u201317741","journal-title":"J Biol Chem"},{"key":"7_CR8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.bbalip.2008.06.005","volume":"1781","author":"J Aoki","year":"2008","unstructured":"Aoki J, Inoue A, Okudaira S (2008) Two pathways for lysophosphatidic acid production. Biochim Biophys Acta 1781:513\u2013518","journal-title":"Biochim Biophys Acta"},{"key":"7_CR9","doi-asserted-by":"crossref","first-page":"39436","DOI":"10.1074\/jbc.M205623200","volume":"277","author":"A Tokumura","year":"2002","unstructured":"Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, Fukuzawa K (2002) Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 277:39436\u201339442","journal-title":"J Biol Chem"},{"key":"7_CR10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1083\/jcb.200204026","volume":"158","author":"M Umezu-Goto","year":"2002","unstructured":"Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J, Arai H (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158:227\u2013233","journal-title":"J Cell Biol"},{"key":"7_CR11","doi-asserted-by":"crossref","first-page":"34254","DOI":"10.1074\/jbc.M201659200","volume":"277","author":"H Sonoda","year":"2002","unstructured":"Sonoda H, Aoki J, Hiramatsu T, Ishida M, Bandoh K, Nagai Y, Taguchi R, Inoue K, Arai H (2002) A novel phosphatidic acid-selective phospholipase A1 that produces lysophosphatidic acid. J Biol Chem 277:34254\u201334263","journal-title":"J Biol Chem"},{"key":"7_CR12","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.semcdb.2004.05.001","volume":"15","author":"J Aoki","year":"2004","unstructured":"Aoki J (2004) Mechanisms of lysophosphatidic acid production. Semin Cell Dev Biol 15:477\u2013489","journal-title":"Semin Cell Dev Biol"},{"key":"7_CR13","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1074\/jbc.273.14.7906","volume":"273","author":"S An","year":"1998","unstructured":"An S, Bleu T, Hallmark OG, Goetzl EJ (1998) Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid. J Biol Chem 273:7906\u20137910","journal-title":"J Biol Chem"},{"key":"7_CR14","doi-asserted-by":"crossref","first-page":"27776","DOI":"10.1074\/jbc.274.39.27776","volume":"274","author":"K Bandoh","year":"1999","unstructured":"Bandoh K, Aoki J, Hosono H, Kobayashi S, Kobayashi T, Murakami-Murofushi K, Tsujimoto M, Arai H, Inoue K (1999) Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid. J Biol Chem 274:27776\u201327785","journal-title":"J Biol Chem"},{"key":"7_CR15","doi-asserted-by":"crossref","first-page":"25600","DOI":"10.1074\/jbc.M302648200","volume":"278","author":"K Noguchi","year":"2003","unstructured":"Noguchi K, Ishii S, Shimizu T (2003) Identification of p2y9\/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family. J Biol Chem 278:25600\u201325606","journal-title":"J Biol Chem"},{"key":"7_CR16","doi-asserted-by":"crossref","first-page":"23589","DOI":"10.1074\/jbc.M603670200","volume":"281","author":"CW Lee","year":"2006","unstructured":"Lee CW, Rivera R, Gardell S, Dubin AE, Chun J (2006) GPR92 as a new G12\/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5. J Biol Chem 281:23589\u201323597","journal-title":"J Biol Chem"},{"key":"7_CR17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nsmb.1980","volume":"18","author":"J Hausmann","year":"2011","unstructured":"Hausmann J, Kamtekar S, Christodoulou E, Day JE, Wu T, Fulkerson Z, Albers HM, van Meeteren LA, Houben AJ, van Zeijl L, Jansen S, Andries M, Hall T, Pegg LE, Benson TE, Kasiem M, Harlos K, Kooi CW, Smyth SS, Ovaa H, Bollen M, Morris AJ, Moolenaar WH, Perrakis A (2011) Structural basis of substrate discrimination and integrin binding by autotaxin. Nat Struct Mol Biol 18:198\u2013204","journal-title":"Nat Struct Mol Biol"},{"key":"7_CR18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nsmb.1998","volume":"18","author":"H Nishimasu","year":"2011","unstructured":"Nishimasu H, Okudaira S, Hama K, Mihara E, Dohmae N, Inoue A, Ishitani R, Takagi J, Aoki J, Nureki O (2011) Crystal structure of autotaxin and insight into GPCR activation by lipid mediators. Nat Struct Mol Biol 18:205\u2013212","journal-title":"Nat Struct Mol Biol"},{"key":"7_CR19","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1021\/jm200310q","volume":"54","author":"HM Albers","year":"2011","unstructured":"Albers HM, Hendrickx LJ, van Tol RJ, Hausmann J, Perrakis A, Ovaa H (2011) Structure-based design of novel boronic acid-based inhibitors of autotaxin. J Med Chem 54:4619\u20134626","journal-title":"J Med Chem"},{"key":"7_CR20","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1021\/cb400150c","volume":"8","author":"M Kawaguchi","year":"2013","unstructured":"Kawaguchi M, Okabe T, Okudaira S, Nishimasu H, Ishitani R, Kojima H, Nureki O, Aoki J, Nagano T (2013) Screening and X-ray crystal structure-based optimization of autotaxin (ENPP2) inhibitors, using a newly developed fluorescence probe. ACS Chem Biol 8:1713\u20131721","journal-title":"ACS Chem Biol"},{"key":"7_CR21","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1124\/mol.115.100404","volume":"88","author":"AJ Stein","year":"2015","unstructured":"Stein AJ, Bain G, Prodanovich P, Santini AM, Darlington J, Stelzer NM, Sidhu RS, Schaub J, Goulet L, Lonergan D, Calderon I, Evans JF, Hutchinson JH (2015) Structural basis for inhibition of human autotaxin by four potent compounds with distinct modes of binding. Mol Pharmacol 88:982\u2013992","journal-title":"Mol Pharmacol"},{"key":"7_CR22","doi-asserted-by":"crossref","first-page":"11248","DOI":"10.1038\/ncomms11248","volume":"7","author":"WJ Keune","year":"2016","unstructured":"Keune WJ, Hausmann J, Bolier R, Tolenaars D, Kremer A, Heidebrecht T, Joosten RP, Sunkara M, Morris AJ, Matas-Rico E, Moolenaar WH, Oude Elferink RP, Perrakis A (2016) Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling. Nat Commun 7:11248","journal-title":"Nat Commun"},{"key":"7_CR23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nsmb.3200","volume":"23","author":"K Kato","year":"2016","unstructured":"Kato K, Ikeda H, Miyakawa S, Futakawa S, Nonaka Y, Fujiwara M, Okudaira S, Kano K, Aoki J, Morita J, Ishitani R, Nishimasu H, Nakamura Y, Nureki O (2016) Structural basis for specific inhibition of Autotaxin by a DNA aptamer. Nat Struct Mol Biol 23:395\u2013401","journal-title":"Nat Struct Mol Biol"},{"key":"7_CR24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsb.2016.06.002","volume":"195","author":"J Hausmann","year":"2016","unstructured":"Hausmann J, Keune WJ, Hipgrave Ederveen AL, van Zeijl L, Joosten RP, Perrakis A (2016) Structural snapshots of the catalytic cycle of the phosphodiesterase Autotaxin. J Struct Biol 195:199\u2013206","journal-title":"J Struct Biol"},{"key":"7_CR25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/acsmedchemlett.6b00207","volume":"7","author":"SB Jones","year":"2016","unstructured":"Jones SB, Pfeifer LA, Bleisch TJ, Beauchamp TJ, Durbin JD, Klimkowski VJ, Hughes NE, Rito CJ, Dao Y, Gruber JM, Bui H, Chambers MG, Chandrasekhar S, Lin C, McCann DJ, Mudra DR, Oskins JL, Swearingen CA, Thirunavukkarasu K, Norman BH (2016) Novel autotaxin inhibitors for the treatment of osteoarthritis pain: lead optimization via structure-based drug design. ACS Med Chem Lett 7:857\u2013861","journal-title":"ACS Med Chem Lett"},{"key":"7_CR26","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1016\/j.bmcl.2016.10.036","volume":"26","author":"P Shah","year":"2016","unstructured":"Shah P, Cheasty A, Foxton C, Raynham T, Farooq M, Gutierrez IF, Lejeune A, Pritchard M, Turnbull A, Pang L, Owen P, Boyd S, Stowell A, Jordan A, Hamilton NM, Hitchin JR, Stockley M, MacDonald E, Quesada MJ, Trivier E, Skeete J, Ovaa H, Moolenaar WH, Ryder H (2016) Discovery of potent inhibitors of the lysophospholipase autotaxin. Bioorg Med Chem Lett 26:5403\u20135410","journal-title":"Bioorg Med Chem Lett"},{"key":"7_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.116.237156","volume":"360","author":"G Bain","year":"2017","unstructured":"Bain G, Shannon KE, Huang F, Darlington J, Goulet L, Prodanovich P, Ma GL, Santini AM, Stein AJ, Lonergan D, King CD, Calderon I, Lai A, Hutchinson JH, Evans JF (2017) Selective inhibition of autotaxin is efficacious in mouse models of liver fibrosis. J Pharmacol Exp Ther 360:1\u201313","journal-title":"J Pharmacol Exp Ther"},{"key":"7_CR28","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/acs.jmedchem.6b01597","volume":"60","author":"LM Miller","year":"2017","unstructured":"Miller LM, Keune WJ, Castagna D, Young LC, Duffy EL, Potjewyd F, Salgado-Polo F, Engel Garcia P, Semaan D, Pritchard JM, Perrakis A, Macdonald SJ, Jamieson C, Watson AJ (2017) Structure-activity relationships of small molecule autotaxin inhibitors with a discrete binding mode. J Med Chem 60:722\u2013748","journal-title":"J Med Chem"},{"key":"7_CR29","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1021\/acs.jmedchem.6b01743","volume":"60","author":"WJ Keune","year":"2017","unstructured":"Keune WJ, Potjewyd F, Heidebrecht T, Salgado-Polo F, Macdonald SJ, Chelvarajan L, Abdel Latif A, Soman S, Morris AJ, Watson AJ, Jamieson C, Perrakis A (2017) Rational design of autotaxin inhibitors by structural evolution of endogenous modulators. J Med Chem 60:2006\u20132017","journal-title":"J Med Chem"},{"key":"7_CR30","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1021\/acs.jmedchem.7b00032","volume":"60","author":"N Desroy","year":"2017","unstructured":"Desroy N, Housseman C, Bock X, Joncour A, Bienvenu N, Cherel L, Labeguere V, Rondet E, Peixoto C, Grassot JM, Picolet O, Annoot D, Triballeau N, Monjardet A, Wakselman E, Roncoroni V, Le Tallec S, Blanque R, Cottereaux C, Vandervoort N, Christophe T, Mollat P, Lamers M, Auberval M, Hrvacic B, Ralic J, Oste L, van der Aar E, Brys R, Heckmann B (2017) Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methyli midazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a first-in-class autotaxin inhibitor undergoing clinical evaluation for the treatment of idiopathic pulmonary fibrosis. J Med Chem 60:3580\u20133590","journal-title":"J Med Chem"},{"key":"7_CR31","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.1021\/acs.jmedchem.7b00647","volume":"60","author":"A Joncour","year":"2017","unstructured":"Joncour A, Desroy N, Housseman C, Bock X, Bienvenu N, Cherel L, Labeguere V, Peixoto C, Annoot D, Lepissier L, Heiermann J, Hengeveld WJ, Pilzak G, Monjardet A, Wakselman E, Roncoroni V, Le Tallec S, Galien R, David C, Vandervoort N, Christophe T, Conrath K, Jans M, Wohlkonig A, Soror S, Steyaert J, Touitou R, Fleury D, Vercheval L, Mollat P, Triballeau N, van der Aar E, Brys R, Heckmann B (2017) Discovery, structure-activity relationship, and binding mode of an imidazo[1,2-a]pyridine series of autotaxin inhibitors. J Med Chem 60:7371\u20137392","journal-title":"J Med Chem"},{"key":"7_CR32","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1021\/acsmedchemlett.7b00312","volume":"8","author":"CA Kuttruff","year":"2017","unstructured":"Kuttruff CA, Ferrara M, Bretschneider T, Hoerer S, Handschuh S, Nosse B, Romig H, Nicklin P, Roth GJ (2017) Discovery of BI-2545: a novel autotaxin inhibitor that significantly reduces LPA levels in vivo. ACS Med Chem Lett 8:1252\u20131257","journal-title":"ACS Med Chem Lett"},{"key":"7_CR33","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.3390\/cancers11101577","volume":"11","author":"F Salgado-Polo","year":"2019","unstructured":"Salgado-Polo F, Perrakis A (2019) The structural binding mode of the four autotaxin inhibitor types that differentially affect catalytic and non-catalytic functions. Cancers (Basel) 11:1577","journal-title":"Cancers (Basel)"},{"key":"7_CR34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1126\/science.1215904","volume":"335","author":"MA Hanson","year":"2012","unstructured":"Hanson MA, Roth CB, Jo E, Griffith MT, Scott FL, Reinhart G, Desale H, Clemons B, Cahalan SM, Schuerer SC, Sanna MG, Han GW, Kuhn P, Rosen H, Stevens RC (2012) Crystal structure of a lipid G protein-coupled receptor. Science 335:851\u2013855","journal-title":"Science"},{"key":"7_CR35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/pro.3509","volume":"28","author":"M Audet","year":"2019","unstructured":"Audet M, Stevens RC (2019) Emerging structural biology of lipid G protein-coupled receptors. Protein Sci 28:292\u2013304","journal-title":"Protein Sci"},{"key":"7_CR36","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.cell.2015.06.002","volume":"161","author":"JE Chrencik","year":"2015","unstructured":"Chrencik JE, Roth CB, Terakado M, Kurata H, Omi R, Kihara Y, Warshaviak D, Nakade S, Asmar-Rovira G, Mileni M, Mizuno H, Griffith MT, Rodgers C, Han GW, Velasquez J, Chun J, Stevens RC, Hanson MA (2015) Crystal structure of antagonist bound human lysophosphatidic acid receptor 1. Cell 161:1633\u20131643","journal-title":"Cell"},{"key":"7_CR37","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nchembio.2547","volume":"14","author":"T Hori","year":"2018","unstructured":"Hori T, Okuno T, Hirata K, Yamashita K, Kawano Y, Yamamoto M, Hato M, Nakamura M, Shimizu T, Yokomizo T, Miyano M, Yokoyama S (2018) Na(+)-mimicking ligands stabilize the inactive state of leukotriene B4 receptor BLT1. Nat Chem Biol 14:262\u2013269","journal-title":"Nat Chem Biol"},{"key":"7_CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41589-018-0160-y","volume":"15","author":"M Audet","year":"2019","unstructured":"Audet M, White KL, Breton B, Zarzycka B, Han GW, Lu Y, Gati C, Batyuk A, Popov P, Velasquez J, Manahan D, Hu H, Weierstall U, Liu W, Shui W, Katritch V, Cherezov V, Hanson MA, Stevens RC (2019) Crystal structure of misoprostol bound to the labor inducer prostaglandin E2 receptor. Nat Chem Biol 15:11\u201317","journal-title":"Nat Chem Biol"},{"key":"7_CR39","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nature23272","volume":"547","author":"T Hua","year":"2017","unstructured":"Hua T, Vemuri K, Nikas SP, Laprairie RB, Wu Y, Qu L, Pu M, Korde A, Jiang S, Ho JH, Han GW, Ding K, Li X, Liu H, Hanson MA, Zhao S, Bohn LM, Makriyannis A, Stevens RC, Liu ZJ (2017) Crystal structures of agonist-bound human cannabinoid receptor CB1. Nature 547:468\u2013471","journal-title":"Nature"},{"key":"7_CR40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2016.10.004","volume":"167","author":"T Hua","year":"2016","unstructured":"Hua T, Vemuri K, Pu M, Qu L, Han GW, Wu Y, Zhao S, Shui W, Li S, Korde A, Laprairie RB, Stahl EL, Ho JH, Zvonok N, Zhou H, Kufareva I, Wu B, Zhao Q, Hanson MA, Bohn LM, Makriyannis A, Stevens RC, Liu ZJ (2016) Crystal Structure of the Human Cannabinoid Receptor CB1. Cell 167:750\u2013762.e714","journal-title":"Cell"},{"key":"7_CR41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nature20613","volume":"540","author":"Z Shao","year":"2016","unstructured":"Shao Z, Yin J, Chapman K, Grzemska M, Clark L, Wang J, Rosenbaum DM (2016) High-resolution crystal structure of the human CB1 cannabinoid receptor. Nature 540:602\u2013606","journal-title":"Nature"},{"key":"7_CR42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature23448","volume":"548","author":"R Taniguchi","year":"2017","unstructured":"Taniguchi R, Inoue A, Sayama M, Uwamizu A, Yamashita K, Hirata K, Yoshida M, Tanaka Y, Kato HE, Nakada-Nakura Y, Otani Y, Nishizawa T, Doi T, Ohwada T, Ishitani R, Aoki J, Nureki O (2017) Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA6. Nature 548:356\u2013360","journal-title":"Nature"},{"key":"7_CR43","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1038\/emboj.2011.296","volume":"30","author":"A Inoue","year":"2011","unstructured":"Inoue A, Arima N, Ishiguro J, Prestwich GD, Arai H, Aoki J (2011) LPA-producing enzyme PA-PLA(1)alpha regulates hair follicle development by modulating EGFR signalling. EMBO J 30:4248\u20134260","journal-title":"EMBO J"},{"key":"7_CR44","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1172\/JCI121955","volume":"130","author":"D Yasuda","year":"2019","unstructured":"Yasuda D, Kobayashi D, Akahoshi N, Ohto-Nakanishi T, Yoshioka K, Takuwa Y, Mizuno S, Takahashi S, Ishii S (2019) Lysophosphatidic acid-induced YAP\/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4. J Clin Invest 130:4332\u20134349","journal-title":"J Clin Invest"},{"key":"7_CR45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/intimm\/dxv072","volume":"28","author":"E Hata","year":"2016","unstructured":"Hata E, Sasaki N, Takeda A, Tohya K, Umemoto E, Akahoshi N, Ishii S, Bando K, Abe T, Kano K, Aoki J, Hayasaka H, Miyasaka M (2016) Lysophosphatidic acid receptors LPA4 and LPA6 differentially promote lymphocyte transmigration across high endothelial venules in lymph nodes. Int Immunol 28:283\u2013292","journal-title":"Int Immunol"},{"key":"7_CR46","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nm1685","volume":"14","author":"AM Tager","year":"2008","unstructured":"Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, Polosukhin V, Wain J, Karimi-Shah BA, Kim ND, Hart WK, Pardo A, Blackwell TS, Xu Y, Chun J, Luster AD (2008) The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 14:45\u201354","journal-title":"Nat Med"},{"key":"7_CR47","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1681\/ASN.2007020196","volume":"18","author":"JP Pradere","year":"2007","unstructured":"Pradere JP, Klein J, Gres S, Guigne C, Neau E, Valet P, Calise D, Chun J, Bascands JL, Saulnier-Blache JS, Schanstra JP (2007) LPA1 receptor activation promotes renal interstitial fibrosis. J Am Soc Nephrol 18:3110\u20133118","journal-title":"J Am Soc Nephrol"},{"key":"7_CR48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1165\/rcmb.2010-0155OC","volume":"46","author":"M Funke","year":"2012","unstructured":"Funke M, Zhao Z, Xu Y, Chun J, Tager AM (2012) The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury. Am J Respir Cell Mol Biol 46:355\u2013364","journal-title":"Am J Respir Cell Mol Biol"},{"key":"7_CR49","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.kint.2016.09.030","volume":"91","author":"N Sakai","year":"2017","unstructured":"Sakai N, Chun J, Duffield JS, Lagares D, Wada T, Luster AD, Tager AM (2017) Lysophosphatidic acid signaling through its receptor initiates profibrotic epithelial cell fibroblast communication mediated by epithelial cell derived connective tissue growth factor. Kidney Int 91:628\u2013641","journal-title":"Kidney Int"},{"key":"7_CR50","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1096\/fj.12-219378","volume":"27","author":"N Sakai","year":"2013","unstructured":"Sakai N, Chun J, Duffield JS, Wada T, Luster AD, Tager AM (2013) LPA1-induced cytoskeleton reorganization drives fibrosis through CTGF-dependent fibroblast proliferation. FASEB J 27:1830\u20131846","journal-title":"FASEB J"},{"key":"7_CR51","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1165\/rcmb.2017-0075OC","volume":"58","author":"RS Knipe","year":"2018","unstructured":"Knipe RS, Probst CK, Lagares D, Franklin A, Spinney JJ, Brazee PL, Grasberger P, Zhang L, Black KE, Sakai N, Shea BS, Liao JK, Medoff BD, Tager AM (2018) The rho kinase isoforms ROCK1 and ROCK2 each contribute to the development of experimental pulmonary fibrosis. Am J Respir Cell Mol Biol 58:471\u2013481","journal-title":"Am J Respir Cell Mol Biol"},{"key":"7_CR52","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1172\/JCI88896","volume":"127","author":"P Cao","year":"2017","unstructured":"Cao P, Aoki Y, Badri L, Walker NM, Manning CM, Lagstein A, Fearon ER, Lama VN (2017) Autocrine lysophosphatidic acid signaling activates beta-catenin and promotes lung allograft fibrosis. J Clin Invest 127:1517\u20131530","journal-title":"J Clin Invest"},{"key":"7_CR53","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/art.30262","volume":"63","author":"FV Castelino","year":"2011","unstructured":"Castelino FV, Seiders J, Bain G, Brooks SF, King CD, Swaney JS, Lorrain DS, Chun J, Luster AD, Tager AM (2011) Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Arthritis Rheum 63:1405\u20131415","journal-title":"Arthritis Rheum"},{"key":"7_CR54","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1111\/j.1476-5381.2010.00828.x","volume":"160","author":"JS Swaney","year":"2010","unstructured":"Swaney JS, Chapman C, Correa LD, Stebbins KJ, Bundey RA, Prodanovich PC, Fagan P, Baccei CS, Santini AM, Hutchinson JH, Seiders TJ, Parr TA, Prasit P, Evans JF, Lorrain DS (2010) A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model. Br J Pharmacol 160:1699\u20131713","journal-title":"Br J Pharmacol"},{"key":"7_CR55","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1124\/jpet.110.175901","volume":"336","author":"JS Swaney","year":"2011","unstructured":"Swaney JS, Chapman C, Correa LD, Stebbins KJ, Broadhead AR, Bain G, Santini AM, Darlington J, King CD, Baccei CS, Lee C, Parr TA, Roppe JR, Seiders TJ, Ziff J, Prasit P, Hutchinson JH, Evans JF, Lorrain DS (2011) Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist. J Pharmacol Exp Ther 336:693\u2013700","journal-title":"J Pharmacol Exp Ther"},{"key":"7_CR56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2011.04.084","volume":"409","author":"L Gan","year":"2011","unstructured":"Gan L, Xue JX, Li X, Liu DS, Ge Y, Ni PY, Deng L, Lu Y, Jiang W (2011) Blockade of lysophosphatidic acid receptors LPAR1\/3 ameliorates lung fibrosis induced by irradiation. Biochem Biophys Res Commun 409:7\u201313","journal-title":"Biochem Biophys Res Commun"},{"key":"7_CR57","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/jcmm.12178","volume":"18","author":"N Tang","year":"2014","unstructured":"Tang N, Zhao Y, Feng R, Liu Y, Wang S, Wei W, Ding Q, An MS, Wen J, Li L (2014) Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts. J Cell Mol Med 18:156\u2013169","journal-title":"J Cell Mol Med"},{"key":"7_CR58","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3109\/01902148.2014.920438","volume":"40","author":"C Cong","year":"2014","unstructured":"Cong C, Mao L, Zhang Y, Zhao Z, Xu X, Zhao J (2014) Regulation of silicosis formation by lysophosphatidic acid and its receptors. Exp Lung Res 40:317\u2013326","journal-title":"Exp Lung Res"},{"key":"7_CR59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pupt.2018.08.003","volume":"52","author":"I Ninou","year":"2018","unstructured":"Ninou I, Kaffe E, Muller S, Budd DC, Stevenson CS, Ullmer C, Aidinis V (2018) Pharmacologic targeting of the ATX\/LPA axis attenuates bleomycin-induced pulmonary fibrosis. Pulm Pharmacol Ther 52:32\u201340","journal-title":"Pulm Pharmacol Ther"},{"key":"7_CR60","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1038\/s41598-019-43576-x","volume":"9","author":"N Sakai","year":"2019","unstructured":"Sakai N, Bain G, Furuichi K, Iwata Y, Nakamura M, Hara A, Kitajima S, Sagara A, Miyake T, Toyama T, Sato K, Nakagawa S, Shimizu M, Kaneko S, Wada T (2019) The involvement of autotaxin in renal interstitial fibrosis through regulation of fibroblast functions and induction of vascular leakage. Sci Rep 9:7414","journal-title":"Sci Rep"},{"key":"7_CR61","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/exd.12752","volume":"24","author":"T Ohashi","year":"2015","unstructured":"Ohashi T, Yamamoto T (2015) Antifibrotic effect of lysophosphatidic acid receptors LPA1 and LPA3 antagonist on experimental murine scleroderma induced by bleomycin. Exp Dermatol 24:698\u2013702","journal-title":"Exp Dermatol"},{"key":"7_CR62","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1165\/rcmb.2013-0070OC","volume":"49","author":"LS Huang","year":"2013","unstructured":"Huang LS, Fu P, Patel P, Harijith A, Sun T, Zhao Y, Garcia JG, Chun J, Natarajan V (2013) Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice. Am J Respir Cell Mol Biol 49:912\u2013922","journal-title":"Am J Respir Cell Mol Biol"},{"key":"7_CR63","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/rcmb.2012-0004OC","volume":"47","author":"N Oikonomou","year":"2012","unstructured":"Oikonomou N, Mouratis MA, Tzouvelekis A, Kaffe E, Valavanis C, Vilaras G, Karameris A, Prestwich GD, Bouros D, Aidinis V (2012) Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Cell Mol Biol 47:566\u2013574","journal-title":"Am J Respir Cell Mol Biol"},{"key":"7_CR64","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.28973","volume":"65","author":"E Kaffe","year":"2017","unstructured":"Kaffe E, Katsifa A, Xylourgidis N, Ninou I, Zannikou M, Harokopos V, Foka P, Dimitriadis A, Evangelou K, Moulas AN, Georgopoulou U, Gorgoulis VG, Dalekos GN, Aidinis V (2017) Hepatocyte autotaxin expression promotes liver fibrosis and cancer. Hepatology 65:1369\u20131383","journal-title":"Hepatology"},{"key":"7_CR65","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1096\/fj.201500197R","volume":"30","author":"KE Black","year":"2016","unstructured":"Black KE, Berdyshev E, Bain G, Castelino FV, Shea BS, Probst CK, Fontaine BA, Bronova I, Goulet L, Lagares D, Ahluwalia N, Knipe RS, Natarajan V, Tager AM (2016) Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis. FASEB J 30:2435\u20132450","journal-title":"FASEB J"},{"key":"7_CR66","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1021\/acs.jmedchem.8b00232","volume":"61","author":"A Nikolaou","year":"2018","unstructured":"Nikolaou A, Ninou I, Kokotou MG, Kaffe E, Afantitis A, Aidinis V, Kokotos G (2018) Hydroxamic acids constitute a novel class of autotaxin inhibitors that exhibit in vivo efficacy in a pulmonary fibrosis model. J Med Chem 61:3697\u20133711","journal-title":"J Med Chem"},{"issue":"1","key":"7_CR67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000502908","volume":"144","author":"M Cortinovis","year":"2020","unstructured":"Cortinovis M, Aiello S, Mister M, Conde-Knape K, Noris M, Novelli R, Solini S, Rodriguez Ordonez PY, Benigni A, Remuzzi G (2020) Autotaxin inhibitor protects from chronic allograft injury in rat kidney allotransplantation. Nephron 144(1):38\u201348","journal-title":"Nephron"},{"key":"7_CR68","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1002\/art.39797","volume":"68","author":"FV Castelino","year":"2016","unstructured":"Castelino FV, Bain G, Pace VA, Black KE, George L, Probst CK, Goulet L, Lafyatis R, Tager AM (2016) An autotaxin\/lysophosphatidic acid\/interleukin-6 amplification loop drives scleroderma fibrosis. Arthritis Rheumatol 68:2964\u20132974","journal-title":"Arthritis Rheumatol"},{"key":"7_CR69","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13075-019-1881-3","volume":"21","author":"T Higuchi","year":"2019","unstructured":"Higuchi T, Takagi K, Tochimoto A, Ichimura Y, Norose T, Katsumata Y, Masuda I, Yamanaka H, Morohoshi T, Kawaguchi Y (2019) Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment. Arthritis Res Ther 21:103","journal-title":"Arthritis Res Ther"},{"key":"7_CR70","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.joca.2014.11.012","volume":"23","author":"L Wu","year":"2015","unstructured":"Wu L, Petrigliano FA, Ba K, Lee S, Bogdanov J, McAllister DR, Adams JS, Rosenthal AK, Van Handel B, Crooks GM, Lin Y, Evseenko D (2015) Lysophosphatidic acid mediates fibrosis in injured joints by regulating collagen type I biosynthesis. Osteoarthr Cartil 23:308\u2013318","journal-title":"Osteoarthr Cartil"},{"key":"7_CR71","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.chest.2018.08.1058","volume":"154","author":"SM Palmer","year":"2018","unstructured":"Palmer SM, Snyder L, Todd JL, Soule B, Christian R, Anstrom K, Luo Y, Gagnon R, Rosen G (2018) Randomized, double-blind, placebo-controlled, phase 2 trial of BMS-986020, a lysophosphatidic acid receptor antagonist for the treatment of idiopathic pulmonary fibrosis. Chest 154:1061\u20131069","journal-title":"Chest"},{"key":"7_CR72","first-page":"A5882","volume":"199","author":"MW Gill","year":"2019","unstructured":"Gill MW, Lakshmi S, Cheng PTW, Murphy BJ, Chadwick K, Lehman-McKeeman L, Graziano M (2019) BMS-986278, an LPA1 receptor antagonist for idiopathic pulmonary fibrosis: preclinical assessments of potential hepatobiliary toxicity. Am J Respir Crit Care Med 199:A5882","journal-title":"Am J Respir Crit Care Med"},{"key":"7_CR73","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/art.40547","volume":"70","author":"Y Allanore","year":"2018","unstructured":"Allanore Y, Distler O, Jagerschmidt A, Illiano S, Ledein L, Boitier E, Agueusop I, Denton CP, Khanna D (2018) Lysophosphatidic acid receptor 1 antagonist SAR100842 for patients with diffuse cutaneous systemic sclerosis: a double-blind, randomized, eight-week placebo-controlled study followed by a sixteen-week open-label extension study. Arthritis Rheumatol 70:1634\u20131643","journal-title":"Arthritis Rheumatol"},{"key":"7_CR74","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-2600(18)30181-4","volume":"6","author":"TM Maher","year":"2018","unstructured":"Maher TM, van der Aar EM, Van de Steen O, Allamassey L, Desrivot J, Dupont S, Fagard L, Ford P, Fieuw A, Wuyts W (2018) Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA): a phase 2a randomised placebo-controlled trial. Lancet Respir Med 6:627\u2013635","journal-title":"Lancet Respir Med"},{"key":"7_CR75","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2019-000422","volume":"6","author":"TM Maher","year":"2019","unstructured":"Maher TM, Kreuter M, Lederer DJ, Brown KK, Wuyts W, Verbruggen N, Stutvoet S, Fieuw A, Ford P, Abi-Saab W, Wijsenbeek M (2019) Rationale, design and objectives of two phase III, randomised, placebo-controlled studies of GLPG1690, a novel autotaxin inhibitor, in idiopathic pulmonary fibrosis (ISABELA 1 and 2). BMJ Open Respir Res 6:e000422","journal-title":"BMJ Open Respir Res"},{"key":"7_CR76","volume":"54","author":"G Lee","year":"2019","unstructured":"Lee G, Kang SU, Ryou JH, Lim JJ, Lee YH (2019) Late breaking abstract\u00a0\u2013 BBT-877, a potent autotaxin inhibitor in clinical development to treat idiopathic pulmonary fibrosis. Eur Respir J 54:PA1293","journal-title":"Eur Respir J"},{"key":"7_CR77","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/cercor\/bhm132","volume":"18","author":"G Estivill-Torr\u00fas","year":"2008","unstructured":"Estivill-Torr\u00fas G, Llebrez-Zayas P, Matas-Rico E, Sant\u00edn L, Pedraza C, De Diego I, Del Arco I, Fern\u00e1ndez-Llebrez P, Chun J, De Fonseca FR (2008) Absence of LPA1 signaling results in defective cortical development. Cereb Cortex 18:938\u2013950","journal-title":"Cereb Cortex"},{"key":"7_CR78","doi-asserted-by":"crossref","first-page":"15444","DOI":"10.1073\/pnas.1106129108","volume":"108","author":"KJ Herr","year":"2011","unstructured":"Herr KJ, Herr DR, Lee CW, Noguchi K, Chun J (2011) Stereotyped fetal brain disorganization is induced by hypoxia and requires lysophosphatidic acid receptor 1 (LPA1) signaling. Proc Natl Acad Sci U S A 108:15444\u201315449","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR79","first-page":"99ra87","volume":"3","author":"YC Yung","year":"2011","unstructured":"Yung YC, Mutoh T, Lin ME, Noguchi K, Rivera RR, Choi JW, Kingsbury MA, Chun J (2011) Lysophosphatidic acid signaling may initiate fetal hydrocephalus. Sci Transl Med 3:99ra87","journal-title":"Sci Transl Med"},{"key":"7_CR80","doi-asserted-by":"crossref","first-page":"eaax2011","DOI":"10.1126\/sciadv.aax2011","volume":"5","author":"NC Lummis","year":"2019","unstructured":"Lummis NC, Sanchez-Pavon P, Kennedy G, Frantz AJ, Kihara Y, Blaho VA, Chun J (2019) LPA1\/3 overactivation induces neonatal posthemorrhagic hydrocephalus through ependymal loss and ciliary dysfunction. Sci Adv 5:eaax2011","journal-title":"Sci Adv"},{"key":"7_CR81","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.33","volume":"5","author":"H Mirendil","year":"2015","unstructured":"Mirendil H, Thomas EA, De Loera C, Okada K, Inomata Y, Chun J (2015) LPA signaling initiates schizophrenia-like brain and behavioral changes in a mouse model of prenatal brain hemorrhage. Transl Psychiatry 5:e541","journal-title":"Transl Psychiatry"},{"key":"7_CR82","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.stemcr.2016.03.002","volume":"6","author":"TL Walker","year":"2016","unstructured":"Walker TL, Overall RW, Vogler S, Sykes AM, Ruhwald S, Lasse D, Ichwan M, Fabel K, Kempermann G (2016) Lysophosphatidic acid receptor is a functional marker of adult hippocampal precursor cells. Stem Cell Reports 6:552\u2013565","journal-title":"Stem Cell Reports"},{"key":"7_CR83","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/adb.12612","volume":"24","author":"D Ladron de Guevara-Miranda","year":"2019","unstructured":"Ladron de Guevara-Miranda D, Moreno-Fernandez RD, Gil-Rodriguez S, Rosell-Valle C, Estivill-Torrus G, Serrano A, Pavon FJ, Rodriguez de Fonseca F, Santin LJ, Castilla-Ortega E (2019) Lysophosphatidic acid-induced increase in adult hippocampal neurogenesis facilitates the forgetting of cocaine-contextual memory. Addict Biol 24:458\u2013470","journal-title":"Addict Biol"},{"key":"7_CR84","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.mcn.2008.07.014","volume":"39","author":"E Matas-Rico","year":"2008","unstructured":"Matas-Rico E, Garcia-Diaz B, Llebrez-Zayas P, Lopez-Barroso D, Santin L, Pedraza C, Smith-Fernandez A, Fernandez-Llebrez P, Tellez T, Redondo M, Chun J, De Fonseca FR, Estivill-Torrus G (2008) Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus. Mol Cell Neurosci 39:342\u2013355","journal-title":"Mol Cell Neurosci"},{"key":"7_CR85","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.mcn.2003.09.001","volume":"24","author":"SM Harrison","year":"2003","unstructured":"Harrison SM, Reavill C, Brown G, Brown JT, Cluderay JE, Crook B, Davies CH, Dawson LA, Grau E, Heidbreder C, Hemmati P, Hervieu G, Howarth A, Hughes ZA, Hunter AJ, Latcham J, Pickering S, Pugh P, Rogers DC, Shilliam CS, Maycox PR (2003) LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease. Mol Cell Neurosci 24:1170\u20131179","journal-title":"Mol Cell Neurosci"},{"key":"7_CR86","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1601-183X.2009.00524.x","volume":"8","author":"LJ Santin","year":"2009","unstructured":"Santin LJ, Bilbao A, Pedraza C, Matas-Rico E, Lopez-Barroso D, Castilla-Ortega E, Sanchez-Lopez J, Riquelme R, Varela-Nieto I, de la Villa P, Suardiaz M, Chun J, De Fonseca FR, Estivill-Torrus G (2009) Behavioral phenotype of maLPA1-null mice: increased anxiety-like behavior and spatial memory deficits. Genes Brain Behav 8:772\u2013784","journal-title":"Genes Brain Behav"},{"key":"7_CR87","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nlm.2010.04.003","volume":"94","author":"E Castilla-Ortega","year":"2010","unstructured":"Castilla-Ortega E, Sanchez-Lopez J, Hoyo-Becerra C, Matas-Rico E, Zambrana-Infantes E, Chun J, De Fonseca FR, Pedraza C, Estivill-Torrus G, Santin LJ (2010) Exploratory, anxiety and spatial memory impairments are dissociated in mice lacking the LPA1 receptor. Neurobiol Learn Mem 94:73\u201382","journal-title":"Neurobiol Learn Mem"},{"key":"7_CR88","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbr.2012.04.018","volume":"232","author":"E Castilla-Ortega","year":"2012","unstructured":"Castilla-Ortega E, Pedraza C, Chun J, de Fonseca FR, Estivill-Torrus G, Santin LJ (2012) Hippocampal c-Fos activation in normal and LPA(1)-null mice after two object recognition tasks with different memory demands. Behav Brain Res 232:400\u2013405","journal-title":"Behav Brain Res"},{"key":"7_CR89","doi-asserted-by":"crossref","first-page":"e1077","DOI":"10.1038\/tp.2017.24","volume":"7","author":"RD Moreno-Fernandez","year":"2017","unstructured":"Moreno-Fernandez RD, Perez-Martin M, Castilla-Ortega E, Del Valle CR, Garcia-Fernandez MI, Chun J, Estivill-Torrus G, de Fonseca FR, Santin LJ, Pedraza C (2017) maLPA1-null mice as an endophenotype of anxious depression. Transl Psychiatry 7:e1077","journal-title":"Transl Psychiatry"},{"key":"7_CR90","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00429-013-0592-9","volume":"219","author":"C Pedraza","year":"2014","unstructured":"Pedraza C, Sanchez-Lopez J, Castilla-Ortega E, Rosell-Valle C, Zambrana-Infantes E, Garcia-Fernandez M, Rodriguez de Fonseca F, Chun J, Santin LJ, Estivill-Torrus G (2014) Fear extinction and acute stress reactivity reveal a role of LPA(1) receptor in regulating emotional-like behaviors. Brain Struct Funct 219:1659\u20131672","journal-title":"Brain Struct Funct"},{"key":"7_CR91","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00213-011-2446-6","volume":"220","author":"E Blanco","year":"2012","unstructured":"Blanco E, Bilbao A, Luque-Rojas MJ, Palomino A, Bermudez-Silva FJ, Suarez J, Santin LJ, Estivill-Torrus G, Gutierrez A, Campos-Sandoval JA, Alonso-Carrion FJ, Marquez J, de Fonseca FR (2012) Attenuation of cocaine-induced conditioned locomotion is associated with altered expression of hippocampal glutamate receptors in mice lacking LPA1 receptors. Psychopharmacology (Berl) 220:27\u201342","journal-title":"Psychopharmacology (Berl)"},{"key":"7_CR92","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuropharm.2015.12.010","volume":"103","author":"E Castilla-Ortega","year":"2016","unstructured":"Castilla-Ortega E, Pavon FJ, Sanchez-Marin L, Estivill-Torrus G, Pedraza C, Blanco E, Suarez J, Santin L, Rodriguez de Fonseca F, Serrano A (2016) Both genetic deletion and pharmacological blockade of lysophosphatidic acid LPA1 receptor results in increased alcohol consumption. Neuropharmacology 103:92\u2013103","journal-title":"Neuropharmacology"},{"key":"7_CR93","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.bbrc.2004.08.004","volume":"322","author":"PK Dash","year":"2004","unstructured":"Dash PK, Orsi SA, Moody M, Moore AN (2004) A role for hippocampal Rho-ROCK pathway in long-term spatial memory. Biochem Biophys Res Commun 322:893\u2013898","journal-title":"Biochem Biophys Res Commun"},{"key":"7_CR94","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085348","volume":"9","author":"E Castilla-Ortega","year":"2014","unstructured":"Castilla-Ortega E, Escuredo L, Bilbao A, Pedraza C, Orio L, Estivill-Torrus G, Santin LJ, de Fonseca FR, Pavon FJ (2014) 1-Oleoyl lysophosphatidic acid: a new mediator of emotional behavior in rats. PLoS One 9:e85348","journal-title":"PLoS One"},{"key":"7_CR95","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00702-014-1289-9","volume":"122","author":"M Yamada","year":"2015","unstructured":"Yamada M, Tsukagoshi M, Hashimoto T, Oka J, Saitoh A, Yamada M (2015) Lysophosphatidic acid induces anxiety-like behavior via its receptors in mice. J Neural Transm (Vienna) 122:487\u2013494","journal-title":"J Neural Transm (Vienna)"},{"key":"7_CR96","doi-asserted-by":"crossref","first-page":"dmm035519","DOI":"10.1242\/dmm.035519","volume":"11","author":"RD Moreno-Fernandez","year":"2018","unstructured":"Moreno-Fernandez RD, Nieto-Quero A, Gomez-Salas FJ, Chun J, Estivill-Torrus G, de Fonseca FR, Santin LJ, Perez-Martin M, Pedraza C (2018) Effects of genetic deletion versus pharmacological blockade of the LPA1 receptor on depression-like behaviour and related brain functional activity. Dis Model Mech 11:dmm035519","journal-title":"Dis Model Mech"},{"key":"7_CR97","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuropharm.2018.01.033","volume":"133","author":"L Sanchez-Marin","year":"2018","unstructured":"Sanchez-Marin L, Ladron de Guevara-Miranda D, Manas-Padilla MC, Alen F, Moreno-Fernandez RD, Diaz-Navarro C, Perez-Del Palacio J, Garcia-Fernandez M, Pedraza C, Pavon FJ, Rodriguez de Fonseca F, Santin LJ, Serrano A, Castilla-Ortega E (2018) Systemic blockade of LPA1\/3 lysophosphatidic acid receptors by ki16425 modulates the effects of ethanol on the brain and behavior. Neuropharmacology 133:189\u2013201","journal-title":"Neuropharmacology"},{"key":"7_CR98","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbalip.2012.08.010","volume":"1831","author":"U Strauss","year":"2013","unstructured":"Strauss U, Brauer AU (2013) Current views on regulation and function of plasticity-related genes (PRGs\/LPPRs) in the brain. Biochim Biophys Acta 1831:133\u2013138","journal-title":"Biochim Biophys Acta"},{"key":"7_CR99","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.cell.2009.06.050","volume":"138","author":"T Trimbuch","year":"2009","unstructured":"Trimbuch T, Beed P, Vogt J, Schuchmann S, Maier N, Kintscher M, Breustedt J, Schuelke M, Streu N, Kieselmann O, Brunk I, Laube G, Strauss U, Battefeld A, Wende H, Birchmeier C, Wiese S, Sendtner M, Kawabe H, Kishimoto-Suga M, Brose N, Baumgart J, Geist B, Aoki J, Savaskan NE, Brauer AU, Chun J, Ninnemann O, Schmitz D, Nitsch R (2009) Synaptic PRG-1 modulates excitatory transmission via lipid phosphate-mediated signaling. Cell 138:1222\u20131235","journal-title":"Cell"},{"key":"7_CR100","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/s41380-018-0053-1","volume":"23","author":"C Thalman","year":"2018","unstructured":"Thalman C, Horta G, Qiao L, Endle H, Tegeder I, Cheng H, Laube G, Sigurdsson T, Hauser MJ, Tenzer S, Distler U, Aoki J, Morris AJ, Geisslinger G, Roper J, Kirischuk S, Luhmann HJ, Radyushkin K, Nitsch R, Vogt J (2018) Synaptic phospholipids as a new target for cortical hyperexcitability and E\/I balance in psychiatric disorders. Mol Psychiatry 23:1699\u20131710","journal-title":"Mol Psychiatry"},{"key":"7_CR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2017.08.032","volume":"336","author":"P Schneider","year":"2018","unstructured":"Schneider P, Petzold S, Sommer A, Nitsch R, Schwegler H, Vogt J, Roskoden T (2018) Altered synaptic phospholipid signaling in PRG-1 deficient mice induces exploratory behavior and motor hyperactivity resembling psychiatric disorders. Behav Brain Res 336:1\u20137","journal-title":"Behav Brain Res"},{"key":"7_CR102","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15252\/emmm.201505677","volume":"8","author":"J Vogt","year":"2016","unstructured":"Vogt J, Yang JW, Mobascher A, Cheng J, Li Y, Liu X, Baumgart J, Thalman C, Kirischuk S, Unichenko P, Horta G, Radyushkin K, Stroh A, Richers S, Sahragard N, Distler U, Tenzer S, Qiao L, Lieb K, Tuscher O, Binder H, Ferreiros N, Tegeder I, Morris AJ, Gropa S, Nurnberg P, Toliat MR, Winterer G, Luhmann HJ, Huai J, Nitsch R (2016) Molecular cause and functional impact of altered synaptic lipid signaling due to a prg-1 gene SNP. EMBO Mol Med 8:25\u201338","journal-title":"EMBO Mol Med"},{"key":"7_CR103","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/1673-5374.264452","volume":"15","author":"I Gross","year":"2020","unstructured":"Gross I, Brauer AU (2020) Modulation of lysophosphatidic acid (LPA) receptor activity: the key to successful neural regeneration? Neural Regen Res 15:53\u201354","journal-title":"Neural Regen Res"},{"key":"7_CR104","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1601-183X.2012.00840.x","volume":"11","author":"Z Callaerts-Vegh","year":"2012","unstructured":"Callaerts-Vegh Z, Leo S, Vermaercke B, Meert T, D\u2019Hooge R (2012) LPA5 receptor plays a role in pain sensitivity, emotional exploration and reversal learning. Genes Brain Behav 11:1009\u20131019","journal-title":"Genes Brain Behav"},{"key":"7_CR105","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nm1060","volume":"10","author":"M Inoue","year":"2004","unstructured":"Inoue M, Rashid MH, Fujita R, Contos JJ, Chun J, Ueda H (2004) Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat Med 10:712\u2013718","journal-title":"Nat Med"},{"key":"7_CR106","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1471-4159.2009.05987.x","volume":"109","author":"L Ma","year":"2009","unstructured":"Ma L, Matsumoto M, Xie W, Inoue M, Ueda H (2009) Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist. J Neurochem 109:603\u2013610","journal-title":"J Neurochem"},{"key":"7_CR107","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pain.2009.07.012","volume":"146","author":"DK Ahn","year":"2009","unstructured":"Ahn DK, Lee SY, Han SR, Ju JS, Yang GY, Lee MK, Youn DH, Bae YC (2009) Intratrigeminal ganglionic injection of LPA causes neuropathic pain-like behavior and demyelination in rats. Pain 146:114\u2013120","journal-title":"Pain"},{"key":"7_CR108","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1471-4159.2010.06664.x","volume":"113","author":"W Xie","year":"2010","unstructured":"Xie W, Uchida H, Nagai J, Ueda M, Chun J, Ueda H (2010) Calpain-mediated down-regulation of myelin-associated glycoprotein in lysophosphatidic acid-induced neuropathic pain. J Neurochem 113:1002\u20131011","journal-title":"J Neurochem"},{"key":"7_CR109","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1744-8069-4-6","volume":"4","author":"M Inoue","year":"2008","unstructured":"Inoue M, Ma L, Aoki J, Chun J, Ueda H (2008) Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Mol Pain 4:6","journal-title":"Mol Pain"},{"key":"7_CR110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1242\/jcs.10.2.535","volume":"10","author":"SM Hall","year":"1972","unstructured":"Hall SM (1972) The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci 10:535\u2013546","journal-title":"J Cell Sci"},{"key":"7_CR111","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuroscience.2007.12.041","volume":"152","author":"M Inoue","year":"2008","unstructured":"Inoue M, Xie W, Matsushita Y, Chun J, Aoki J, Ueda H (2008) Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Neuroscience 152:296\u2013298","journal-title":"Neuroscience"},{"key":"7_CR112","first-page":"64","volume":"5","author":"L Ma","year":"2009","unstructured":"Ma L, Uchida H, Nagai J, Inoue M, Chun J, Aoki J, Ueda H (2009) Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain. Mol Pain 5:64","journal-title":"Mol Pain"},{"key":"7_CR113","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1744-8069-6-78","volume":"6","author":"J Nagai","year":"2010","unstructured":"Nagai J, Uchida H, Matsushita Y, Yano R, Ueda M, Niwa M, Aoki J, Chun J, Ueda H (2010) Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine. Mol Pain 6:78","journal-title":"Mol Pain"},{"key":"7_CR114","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1471-4159.2010.06955.x","volume":"115","author":"L Ma","year":"2010","unstructured":"Ma L, Nagai J, Ueda H (2010) Microglial activation mediates de novo lysophosphatidic acid production in a model of neuropathic pain. J Neurochem 115:643\u2013653","journal-title":"J Neurochem"},{"key":"7_CR115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1744-8069-10-71","volume":"10","author":"H Uchida","year":"2014","unstructured":"Uchida H, Nagai J, Ueda H (2014) Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice. Mol Pain 10:71","journal-title":"Mol Pain"},{"key":"7_CR116","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.joca.2016.08.016","volume":"25","author":"JJ McDougall","year":"2017","unstructured":"McDougall JJ, Albacete S, Schuelert N, Mitchell PG, Lin C, Oskins JL, Bui HH, Chambers MG (2017) Lysophosphatidic acid provides a missing link between osteoarthritis and joint neuropathic pain. Osteoarthr Cartil 25:926\u2013934","journal-title":"Osteoarthr Cartil"},{"key":"7_CR117","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuroscience.2013.01.005","volume":"235","author":"SK Halder","year":"2013","unstructured":"Halder SK, Yano R, Chun J, Ueda H (2013) Involvement of LPA1 receptor signaling in cerebral ischemia-induced neuropathic pain. Neuroscience 235:10\u201315","journal-title":"Neuroscience"},{"key":"7_CR118","doi-asserted-by":"crossref","first-page":"100020","DOI":"10.1016\/j.ynpai.2018.07.001","volume":"5","author":"H Ueda","year":"2019","unstructured":"Ueda H, Neyama H, Sasaki K, Miyama C, Iwamoto R (2019) Lysophosphatidic acid LPA1 and LPA3 receptors play roles in the maintenance of late tissue plasminogen activator-induced central poststroke pain in mice. Neurobiol Pain 5:100020","journal-title":"Neurobiol Pain"},{"key":"7_CR119","doi-asserted-by":"crossref","first-page":"17608","DOI":"10.1074\/jbc.M111.330183","volume":"287","author":"ME Lin","year":"2012","unstructured":"Lin ME, Rivera RR, Chun J (2012) Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain. J Biol Chem 287:17608\u201317617","journal-title":"J Biol Chem"},{"key":"7_CR120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jphs.2018.01.001","volume":"136","author":"R Tsukahara","year":"2018","unstructured":"Tsukahara R, Yamamoto S, Yoshikawa K, Gotoh M, Tsukahara T, Neyama H, Ishii S, Akahoshi N, Yanagida K, Sumida H, Araki M, Araki K, Yamamura KI, Murakami-Murofushi K, Ueda H (2018) LPA5 signaling is involved in multiple sclerosis-mediated neuropathic pain in the cuprizone mouse model. J Pharmacol Sci 136:93\u201396","journal-title":"J Pharmacol Sci"},{"key":"7_CR121","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2017.08.032","volume":"126","author":"N Murai","year":"2017","unstructured":"Murai N, Hiyama H, Kiso T, Sekizawa T, Watabiki T, Oka H, Aoki T (2017) Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents. Neuropharmacology 126:97\u2013107","journal-title":"Neuropharmacology"},{"key":"7_CR122","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bmc.2017.11.038","volume":"26","author":"Y Kawamoto","year":"2018","unstructured":"Kawamoto Y, Seo R, Murai N, Hiyama H, Oka H (2018) Identification of potent lysophosphatidic acid receptor 5 (LPA5) antagonists as potential analgesic agents. Bioorg Med Chem 26:257\u2013265","journal-title":"Bioorg Med Chem"},{"key":"7_CR123","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1128\/MCB.02419-05","volume":"26","author":"LA van Meeteren","year":"2006","unstructured":"van Meeteren LA, Ruurs P, Stortelers C, Bouwman P, van Rooijen MA, Pradere JP, Pettit TR, Wakelam MJ, Saulnier-Blache JS, Mummery CL, Moolenaar WH, Jonkers J (2006) Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development. Mol Cell Biol 26:5015\u20135022","journal-title":"Mol Cell Biol"},{"key":"7_CR124","doi-asserted-by":"crossref","first-page":"25822","DOI":"10.1074\/jbc.M605142200","volume":"281","author":"M Tanaka","year":"2006","unstructured":"Tanaka M, Okudaira S, Kishi Y, Ohkawa R, Iseki S, Ota M, Noji S, Yatomi Y, Aoki J, Arai H (2006) Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid. J Biol Chem 281:25822\u201325830","journal-title":"J Biol Chem"},{"key":"7_CR125","doi-asserted-by":"crossref","first-page":"33561","DOI":"10.1074\/jbc.M109.012716","volume":"284","author":"S Koike","year":"2009","unstructured":"Koike S, Keino-Masu K, Ohto T, Sugiyama F, Takahashi S, Masu M (2009) Autotaxin\/lysophospholipase D-mediated lysophosphatidic acid signaling is required to form distinctive large lysosomes in the visceral endoderm cells of the mouse yolk sac. J Biol Chem 284:33561\u201333570","journal-title":"J Biol Chem"},{"key":"7_CR126","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ydbio.2010.01.007","volume":"339","author":"S Fotopoulou","year":"2010","unstructured":"Fotopoulou S, Oikonomou N, Grigorieva E, Nikitopoulou I, Paparountas T, Thanassopoulou A, Zhao Z, Xu Y, Kontoyiannis DL, Remboutsika E, Aidinis V (2010) ATX expression and LPA signalling are vital for the development of the nervous system. Dev Biol 339:451\u2013464","journal-title":"Dev Biol"},{"key":"7_CR127","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126734","volume":"10","author":"H Yukiura","year":"2015","unstructured":"Yukiura H, Kano K, Kise R, Inoue A, Aoki J (2015) Autotaxin overexpression causes embryonic lethality and vascular defects. PLoS One 10:e0126734","journal-title":"PLoS One"},{"key":"7_CR128","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1242\/dev.00635","volume":"130","author":"D Escalante-Alcalde","year":"2003","unstructured":"Escalante-Alcalde D, Hernandez L, Le Stunff H, Maeda R, Lee HS, Jr Gang C, Sciorra VA, Daar I, Spiegel S, Morris AJ, Stewart CL (2003) The lipid phosphatase LPP3 regulates extra-embryonic vasculogenesis and axis patterning. Development 130:4623\u20134637","journal-title":"Development"},{"key":"7_CR129","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.275.5299.533","volume":"275","author":"S Offermanns","year":"1997","unstructured":"Offermanns S, Mancino V, Revel JP, Simon MI (1997) Vascular system defects and impaired cell chemokinesis as a result of Galpha13 deficiency. Science 275:533\u2013536","journal-title":"Science"},{"key":"7_CR130","doi-asserted-by":"crossref","first-page":"9352","DOI":"10.1073\/pnas.102291599","volume":"99","author":"JL Gu","year":"2002","unstructured":"Gu JL, Muller S, Mancino V, Offermanns S, Simon MI (2002) Interaction of G alpha(12) with G alpha(13) and G alpha(q) signaling pathways. Proc Natl Acad Sci U S A 99:9352\u20139357","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR131","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.1073\/pnas.0503326102","volume":"102","author":"KM Ruppel","year":"2005","unstructured":"Ruppel KM, Willison D, Kataoka H, Wang A, Zheng YW, Cornelissen I, Yin L, Xu SM, Coughlin SR (2005) Essential role for Galpha13 in endothelial cells during embryonic development. Proc Natl Acad Sci U S A 102:8281\u20138286","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR132","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1182\/blood-2010-03-272443","volume":"116","author":"H Sumida","year":"2010","unstructured":"Sumida H, Noguchi K, Kihara Y, Abe M, Yanagida K, Hamano F, Sato S, Tamaki K, Morishita Y, Kano MR, Iwata C, Miyazono K, Sakimura K, Shimizu T, Ishii S (2010) LPA4 regulates blood and lymphatic vessel formation during mouse embryogenesis. Blood 116:5060\u20135070","journal-title":"Blood"},{"key":"7_CR133","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.celrep.2017.07.080","volume":"20","author":"K Takara","year":"2017","unstructured":"Takara K, Eino D, Ando K, Yasuda D, Naito H, Tsukada Y, Iba T, Wakabayashi T, Muramatsu F, Kidoya H, Fukuhara S, Mochizuki N, Ishii S, Kishima H, Takakura N (2017) Lysophosphatidic acid receptor 4 activation augments drug delivery in tumors by tightening endothelial cell-cell contact. Cell Rep 20:2072\u20132086","journal-title":"Cell Rep"},{"key":"7_CR134","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1158\/0008-5472.CAN-18-0498","volume":"78","author":"D Eino","year":"2018","unstructured":"Eino D, Tsukada Y, Naito H, Kanemura Y, Iba T, Wakabayashi T, Muramatsu F, Kidoya H, Arita H, Kagawa N, Fujimoto Y, Takara K, Kishima H, Takakura N (2018) LPA4-mediated vascular network formation increases the efficacy of anti-PD-1 therapy against brain tumors. Cancer Res 78:6607\u20136620","journal-title":"Cancer Res"},{"key":"7_CR135","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCRESAHA.108.180778","volume":"103","author":"M Panchatcharam","year":"2008","unstructured":"Panchatcharam M, Miriyala S, Yang F, Rojas M, End C, Vallant C, Dong A, Lynch K, Chun J, Morris AJ, Smyth SS (2008) Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure. Circ Res 103:662\u2013670","journal-title":"Circ Res"},{"key":"7_CR136","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1038\/s41598-019-39041-4","volume":"9","author":"K Kano","year":"2019","unstructured":"Kano K, Matsumoto H, Inoue A, Yukiura H, Kanai M, Chun J, Ishii S, Shimizu T, Aoki J (2019) Molecular mechanism of lysophosphatidic acid-induced hypertensive response. Sci Rep 9:2662","journal-title":"Sci Rep"},{"key":"7_CR137","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.atherosclerosis.2013.03.038","volume":"229","author":"T Dohi","year":"2013","unstructured":"Dohi T, Miyauchi K, Ohkawa R, Nakamura K, Kurano M, Kishimoto T, Yanagisawa N, Ogita M, Miyazaki T, Nishino A, Yaginuma K, Tamura H, Kojima T, Yokoyama K, Kurata T, Shimada K, Daida H, Yatomi Y (2013) Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome. Atherosclerosis 229:192\u2013197","journal-title":"Atherosclerosis"},{"key":"7_CR138","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/ATVBAHA.114.304748","volume":"35","author":"M Kurano","year":"2015","unstructured":"Kurano M, Suzuki A, Inoue A, Tokuhara Y, Kano K, Matsumoto H, Igarashi K, Ohkawa R, Nakamura K, Dohi T, Miyauchi K, Daida H, Tsukamoto K, Ikeda H, Aoki J, Yatomi Y (2015) Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome. Arterioscler Thromb Vasc Biol 35:463\u2013470","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7_CR139","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1161\/01.CIR.0000089374.35455.F3","volume":"108","author":"K Yoshida","year":"2003","unstructured":"Yoshida K, Nishida W, Hayashi K, Ohkawa Y, Ogawa A, Aoki J, Arai H, Sobue K (2003) Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Circulation 108:1746\u20131752","journal-title":"Circulation"},{"key":"7_CR140","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1084\/jem.20031619","volume":"199","author":"C Zhang","year":"2004","unstructured":"Zhang C, Baker DL, Yasuda S, Makarova N, Balazs L, Johnson LR, Marathe GK, McIntyre TM, Xu Y, Prestwich GD, Byun HS, Bittman R, Tigyi G (2004) Lysophosphatidic acid induces neointima formation through PPARgamma activation. J Exp Med 199:763\u2013774","journal-title":"J Exp Med"},{"key":"7_CR141","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCRESAHA.109.212647","volume":"107","author":"P Subramanian","year":"2010","unstructured":"Subramanian P, Karshovska E, Reinhard P, Megens RT, Zhou Z, Akhtar S, Schumann U, Li X, van Zandvoort M, Ludin C, Weber C, Schober A (2010) Lysophosphatidic acid receptors LPA1 and LPA3 promote CXCL12-mediated smooth muscle progenitor cell recruitment in neointima formation. Circ Res 107:96\u2013105","journal-title":"Circ Res"},{"key":"7_CR142","doi-asserted-by":"crossref","first-page":"C975","DOI":"10.1152\/ajpcell.00227.2016","volume":"311","author":"F Hao","year":"2016","unstructured":"Hao F, Zhang F, Wu DD, An D, Shi J, Li G, Xu X, Cui MZ (2016) Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1\/Cyr61. Am J Physiol Cell Physiol 311:C975\u2013c984","journal-title":"Am J Physiol Cell Physiol"},{"key":"7_CR143","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/ATVBAHA.112.300527","volume":"33","author":"M Panchatcharam","year":"2013","unstructured":"Panchatcharam M, Miriyala S, Salous A, Wheeler J, Dong A, Mueller P, Sunkara M, Escalante-Alcalde D, Morris AJ, Smyth SS (2013) Lipid phosphate phosphatase 3 negatively regulates smooth muscle cell phenotypic modulation to limit intimal hyperplasia. Arterioscler Thromb Vasc Biol 33:52\u201359","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7_CR144","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1016\/j.cellsig.2009.08.003","volume":"21","author":"Y Cheng","year":"2009","unstructured":"Cheng Y, Makarova N, Tsukahara R, Guo H, Shuyu E, Farrar P, Balazs L, Zhang C, Tigyi G (2009) Lysophosphatidic acid-induced arterial wall remodeling: requirement of PPARgamma but not LPA1 or LPA2 GPCR. Cell Signal 21:1874\u20131884","journal-title":"Cell Signal"},{"key":"7_CR145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/ATVBAHA.111.234708","volume":"32","author":"HY Cheng","year":"2012","unstructured":"Cheng HY, Dong A, Panchatcharam M, Mueller P, Yang F, Li Z, Mills G, Chun J, Morris AJ, Smyth SS (2012) Lysophosphatidic acid signaling protects pulmonary vasculature from hypoxia-induced remodeling. Arterioscler Thromb Vasc Biol 32:24\u201332","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7_CR146","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1073\/pnas.96.12.6931","volume":"96","author":"W Siess","year":"1999","unstructured":"Siess W, Zangl KJ, Essler M, Bauer M, Brandl R, Corrinth C, Bittman R, Tigyi G, Aepfelbacher M (1999) Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions. Proc Natl Acad Sci U S A 96:6931\u20136936","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR147","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.cmet.2011.02.016","volume":"13","author":"Z Zhou","year":"2011","unstructured":"Zhou Z, Subramanian P, Sevilmis G, Globke B, Soehnlein O, Karshovska E, Megens R, Heyll K, Chun J, Saulnier-Blache JS, Reinholz M, van Zandvoort M, Weber C, Schober A (2011) Lipoprotein-derived lysophosphatidic acid promotes atherosclerosis by releasing CXCL1 from the endothelium. Cell Metab 13:592\u2013600","journal-title":"Cell Metab"},{"key":"7_CR148","doi-asserted-by":"crossref","first-page":"37585","DOI":"10.1038\/srep37585","volume":"6","author":"E Kritikou","year":"2016","unstructured":"Kritikou E, van Puijvelde GH, van der Heijden T, van Santbrink PJ, Swart M, Schaftenaar FH, Kroner MJ, Kuiper J, Bot I (2016) Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice. Sci Rep 6:37585","journal-title":"Sci Rep"},{"key":"7_CR149","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1093\/cvr\/cvx089","volume":"113","author":"MJ Nsaibia","year":"2017","unstructured":"Nsaibia MJ, Boulanger MC, Bouchareb R, Mkannez G, Le Quang K, Hadji F, Argaud D, Dahou A, Bosse Y, Koschinsky ML, Pibarot P, Arsenault BJ, Marette A, Mathieu P (2017) OxLDL-derived lysophosphatidic acid promotes the progression of aortic valve stenosis through a LPAR1-RhoA-NF-kappaB pathway. Cardiovasc Res 113:1351\u20131363","journal-title":"Cardiovasc Res"},{"key":"7_CR150","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1194\/jlr.M091066","volume":"60","author":"L Yang","year":"2019","unstructured":"Yang L, Kraemer M, Fang XF, Angel PM, Drake RR, Morris AJ, Smyth SS (2019) LPA receptor 4 deficiency attenuates experimental atherosclerosis. J Lipid Res 60:972\u2013980","journal-title":"J Lipid Res"},{"key":"7_CR151","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1161\/ATVBAHA.119.313056","volume":"39","author":"PA Mueller","year":"2019","unstructured":"Mueller PA, Yang L, Ubele M, Mao G, Brandon J, Vandra J, Nichols TC, Escalante-Alcalde D, Morris AJ, Smyth SS (2019) Coronary artery disease risk-associated Plpp3 gene and its product lipid phosphate phosphatase 3 regulate experimental atherosclerosis. Arterioscler Thromb Vasc Biol 39:2261\u20132272","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7_CR152","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/ng.784","volume":"43","author":"H Schunkert","year":"2011","unstructured":"Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AF, Barbalic M, Gieger C, Absher D, Aherrahrou Z, Allayee H, Altshuler D, Anand SS, Andersen K, Anderson JL, Ardissino D, Ball SG, Balmforth AJ, Barnes TA, Becker DM, Becker LC, Berger K, Bis JC, Boekholdt SM, Boerwinkle E, Braund PS, Brown MJ, Burnett MS, Buysschaert I, Carlquist JF, Chen L, Cichon S, Codd V, Davies RW, Dedoussis G, Dehghan A, Demissie S, Devaney JM, Diemert P, Do R, Doering A, Eifert S, Mokhtari NE, Ellis SG, Elosua R, Engert JC, Epstein SE, de Faire U, Fischer M, Folsom AR, Freyer J, Gigante B, Girelli D, Gretarsdottir S, Gudnason V, Gulcher JR, Halperin E, Hammond N, Hazen SL, Hofman A, Horne BD, Illig T, Iribarren C, Jones GT, Jukema JW, Kaiser MA, Kaplan LM, Kastelein JJ, Khaw KT, Knowles JW, Kolovou G, Kong A, Laaksonen R, Lambrechts D, Leander K, Lettre G, Li M, Lieb W, Loley C, Lotery AJ, Mannucci PM, Maouche S, Martinelli N, McKeown PP, Meisinger C, Meitinger T, Melander O, Merlini PA, Mooser V, Morgan T, Muhleisen TW, Muhlestein JB, Munzel T, Musunuru K, Nahrstaedt J, Nelson CP, Nothen MM, Olivieri O, Patel RS, Patterson CC, Peters A, Peyvandi F, Qu L, Quyyumi AA, Rader DJ, Rallidis LS, Rice C, Rosendaal FR, Rubin D, Salomaa V, Sampietro ML, Sandhu MS, Schadt E, Schafer A, Schillert A, Schreiber S, Schrezenmeir J, Schwartz SM, Siscovick DS, Sivananthan M, Sivapalaratnam S, Smith A, Smith TB, Snoep JD, Soranzo N, Spertus JA, Stark K, Stirrups K, Stoll M, Tang WH, Tennstedt S, Thorgeirsson G, Thorleifsson G, Tomaszewski M, Uitterlinden AG, van Rij AM, Voight BF, Wareham NJ, Wells GA, Wichmann HE, Wild PS, Willenborg C, Witteman JC, Wright BJ, Ye S, Zeller T, Ziegler A, Cambien F, Goodall AH, Cupples LA, Quertermous T, Marz W, Hengstenberg C, Blankenberg S, Ouwehand WH, Hall AS, Deloukas P, Thompson JR, Stefansson K, Roberts R, Thorsteinsdottir U, O\u2019Donnell CJ, McPherson R, Erdmann J, Samani NJ (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43:333\u2013338","journal-title":"Nat Genet"},{"key":"7_CR153","doi-asserted-by":"crossref","first-page":"44503","DOI":"10.1038\/srep44503","volume":"7","author":"M Busnelli","year":"2017","unstructured":"Busnelli M, Manzini S, Hilvo M, Parolini C, Ganzetti GS, Dellera F, Ekroos K, Janis M, Escalante-Alcalde D, Sirtori CR, Laaksonen R, Chiesa G (2017) Liver-specific deletion of the Plpp3 gene alters plasma lipid composition and worsens atherosclerosis in apoE(-\/-) mice. Sci Rep 7:44503","journal-title":"Sci Rep"},{"key":"7_CR154","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/ATVBAHA.113.302335","volume":"34","author":"M Panchatcharam","year":"2014","unstructured":"Panchatcharam M, Salous AK, Brandon J, Miriyala S, Wheeler J, Patil P, Sunkara M, Morris AJ, Escalante-Alcalde D, Smyth SS (2014) Mice with targeted inactivation of ppap2b in endothelial and hematopoietic cells display enhanced vascular inflammation and permeability. Arterioscler Thromb Vasc Biol 34:837\u2013845","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7_CR155","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.redox.2017.09.015","volume":"14","author":"M Chandra","year":"2018","unstructured":"Chandra M, Escalante-Alcalde D, Bhuiyan MS, Orr AW, Kevil C, Morris AJ, Nam H, Dominic P, McCarthy KJ, Miriyala S, Panchatcharam M (2018) Cardiac-specific inactivation of LPP3 in mice leads to myocardial dysfunction and heart failure. Redox Biol 14:261\u2013271","journal-title":"Redox Biol"},{"key":"7_CR156","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphys.2017.00356","volume":"8","author":"L Cai","year":"2017","unstructured":"Cai L, Fan G, Wang F, Liu S, Li T, Cong X, Chun J, Chen X (2017) Protective role for LPA3 in cardiac hypertrophy induced by myocardial infarction but not by isoproterenol. Front Physiol 8:356","journal-title":"Front Physiol"},{"key":"7_CR157","first-page":"153","volume":"8","author":"H Chen","year":"2017","unstructured":"Chen H, Liu S, Liu X, Yang J, Wang F, Cong X, Chen X (2017) Lysophosphatidic acid pretreatment attenuates myocardial ischemia\/reperfusion injury in the immature hearts of rats. Front Physiol 8:153","journal-title":"Front Physiol"},{"key":"7_CR158","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/00365510310003265","volume":"63","author":"X Chen","year":"2003","unstructured":"Chen X, Yang XY, Wang ND, Ding C, Yang YJ, You ZJ, Su Q, Chen JH (2003) Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction. Scand J Clin Lab Invest 63:497\u2013503","journal-title":"Scand J Clin Lab Invest"},{"key":"7_CR159","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1165\/rcmb.2015-0152OC","volume":"55","author":"M Funke","year":"2016","unstructured":"Funke M, Knudsen L, Lagares D, Ebener S, Probst CK, Fontaine BA, Franklin A, Kellner M, Kuhnel M, Matthieu S, Grothausmann R, Chun J, Roberts JD Jr, Ochs M, Tager AM (2016) Lysophosphatidic acid signaling through the lysophosphatidic acid-1 receptor is required for alveolarization. Am J Respir Cell Mol Biol 55:105\u2013116","journal-title":"Am J Respir Cell Mol Biol"},{"key":"7_CR160","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/apha.12622","volume":"216","author":"X Chen","year":"2016","unstructured":"Chen X, Walther FJ, van Boxtel R, Laghmani EH, Sengers RM, Folkerts G, DeRuiter MC, Cuppen E, Wagenaar GT (2016) Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats. Acta Physiol (Oxf) 216:358\u2013375","journal-title":"Acta Physiol (Oxf)"},{"key":"7_CR161","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133619","volume":"10","author":"MA Mouratis","year":"2015","unstructured":"Mouratis MA, Magkrioti C, Oikonomou N, Katsifa A, Prestwich GD, Kaffe E, Aidinis V (2015) Autotaxin and endotoxin-induced acute lung injury. PLoS One 10:e0133619","journal-title":"PLoS One"},{"key":"7_CR162","doi-asserted-by":"crossref","first-page":"L547","DOI":"10.1152\/ajplung.00058.2011","volume":"301","author":"J Zhao","year":"2011","unstructured":"Zhao J, He D, Su Y, Berdyshev E, Chun J, Natarajan V, Zhao Y (2011) Lysophosphatidic acid receptor 1 modulates lipopolysaccharide-induced inflammation in alveolar epithelial cells and murine lungs. Am J Physiol Lung Cell Mol Physiol 301:L547\u2013L556","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"7_CR163","first-page":"155","volume":"8","author":"X Chen","year":"2017","unstructured":"Chen X, Walther FJ, Laghmani EH, Hoogeboom AM, Hogen-Esch AC, van Ark I, Folkerts G, Wagenaar GT (2017) Adult lysophosphatidic acid receptor 1-deficient rats with hyperoxia-induced neonatal chronic lung disease are protected against lipopolysaccharide-induced acute lung injury. Front Physiol 8:155","journal-title":"Front Physiol"},{"key":"7_CR164","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11302-015-9463-6","volume":"11","author":"M Nowak-Machen","year":"2015","unstructured":"Nowak-Machen M, Lange M, Exley M, Wu S, Usheva A, Robson SC (2015) Lysophosphatidic acid generation by pulmonary NKT cell ENPP-2\/autotaxin exacerbates hyperoxic lung injury. Purinergic Signal 11:455\u2013461","journal-title":"Purinergic Signal"},{"key":"7_CR165","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1164\/rccm.201306-1014OC","volume":"188","author":"GY Park","year":"2013","unstructured":"Park GY, Lee YG, Berdyshev E, Nyenhuis S, Du J, Fu P, Gorshkova IA, Li Y, Chung S, Karpurapu M, Deng J, Ranjan R, Xiao L, Jaffe HA, Corbridge SJ, Kelly EA, Jarjour NN, Chun J, Prestwich GD, Kaffe E, Ninou I, Aidinis V, Morris AJ, Smyth SS, Ackerman SJ, Natarajan V, Christman JW (2013) Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation. Am J Respir Crit Care Med 188:928\u2013940","journal-title":"Am J Respir Crit Care Med"},{"key":"7_CR166","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1465-9921-10-114","volume":"10","author":"Y Zhao","year":"2009","unstructured":"Zhao Y, Tong J, He D, Pendyala S, Evgeny B, Chun J, Sperling AI, Natarajan V (2009) Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma. Respir Res 10:114","journal-title":"Respir Res"},{"key":"7_CR167","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.4049\/jimmunol.1102956","volume":"188","author":"J Emo","year":"2012","unstructured":"Emo J, Meednu N, Chapman TJ, Rezaee F, Balys M, Randall T, Rangasamy T, Georas SN (2012) Lpa2 is a negative regulator of both dendritic cell activation and murine models of allergic lung inflammation. J Immunol 188:3784\u20133790","journal-title":"J Immunol"},{"key":"7_CR168","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1165\/rcmb.2015-0124OC","volume":"54","author":"SA Knowlden","year":"2016","unstructured":"Knowlden SA, Hillman SE, Chapman TJ, Patil R, Miller DD, Tigyi G, Georas SN (2016) Novel inhibitory effect of a lysophosphatidic acid 2 agonist on allergen-driven airway inflammation. Am J Respir Cell Mol Biol 54:402\u2013409","journal-title":"Am J Respir Cell Mol Biol"},{"key":"7_CR169","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0101655","volume":"9","author":"SA Knowlden","year":"2014","unstructured":"Knowlden SA, Capece T, Popovic M, Chapman TJ, Rezaee F, Kim M, Georas SN (2014) Regulation of T cell motility in vitro and in vivo by LPA and LPA2. PLoS One 9:e101655","journal-title":"PLoS One"},{"key":"7_CR170","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.10561","volume":"5","author":"A Takeda","year":"2016","unstructured":"Takeda A, Kobayashi D, Aoi K, Sasaki N, Sugiura Y, Igarashi H, Tohya K, Inoue A, Hata E, Akahoshi N, Hayasaka H, Kikuta J, Scandella E, Ludewig B, Ishii S, Aoki J, Suematsu M, Ishii M, Takeda K, Jalkanen S, Miyasaka M, Umemoto E (2016) Fibroblastic reticular cell-derived lysophosphatidic acid regulates confined intranodal T-cell motility. Elife 5:e10561","journal-title":"Elife"},{"key":"7_CR171","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1038\/s41467-018-06189-y","volume":"9","author":"NG Jendzjowsky","year":"2018","unstructured":"Jendzjowsky NG, Roy A, Barioni NO, Kelly MM, Green FHY, Wyatt CN, Pye RL, Tenorio-Lopes L, Wilson RJA (2018) Preventing acute asthmatic symptoms by targeting a neuronal mechanism involving carotid body lysophosphatidic acid receptors. Nat Commun 9:4030","journal-title":"Nat Commun"},{"key":"7_CR172","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/MCB.00038-13","volume":"33","author":"SJ Lee","year":"2013","unstructured":"Lee SJ, Leoni G, Neumann PA, Chun J, Nusrat A, Yun CC (2013) Distinct phospholipase C-beta isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure. Mol Cell Biol 33:2016\u20132028","journal-title":"Mol Cell Biol"},{"key":"7_CR173","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ajpath.2017.10.006","volume":"188","author":"S Lin","year":"2018","unstructured":"Lin S, Han Y, Jenkin K, Lee SJ, Sasaki M, Klapproth JM, He P, Yun CC (2018) Lysophosphatidic acid receptor 1 is important for intestinal epithelial barrier function and susceptibility to colitis. Am J Pathol 188:353\u2013366","journal-title":"Am J Pathol"},{"key":"7_CR174","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1096\/fj.201801415RR","volume":"33","author":"S Lin","year":"2019","unstructured":"Lin S, Haque A, Raeman R, Guo L, He P, Denning TL, El-Rayes B, Moolenaar WH, Yun CC (2019) Autotaxin determines colitis severity in mice and is secreted by B cells in the colon. FASEB J 33:3623\u20133635","journal-title":"FASEB J"},{"key":"7_CR175","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/gast.1999.0029900368","volume":"117","author":"A Sturm","year":"1999","unstructured":"Sturm A, Sudermann T, Schulte KM, Goebell H, Dignass AU (1999) Modulation of intestinal epithelial wound healing in vitro and in vivo by lysophosphatidic acid. Gastroenterology 117:368\u2013377","journal-title":"Gastroenterology"},{"key":"7_CR176","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1007\/s10620-011-1595-0","volume":"56","author":"M Adachi","year":"2011","unstructured":"Adachi M, Horiuchi G, Ikematsu N, Tanaka T, Terao J, Satouchi K, Tokumura A (2011) Intragastrically administered lysophosphatidic acids protect against gastric ulcer in rats under water-immersion restraint stress. Dig Dis Sci 56:2252\u20132261","journal-title":"Dig Dis Sci"},{"key":"7_CR177","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1007\/s10753-019-01015-z","volume":"42","author":"YL Dong","year":"2019","unstructured":"Dong YL, Duan XY, Liu YJ, Fan H, Xu M, Chen QY, Nan Z, Wu H, Deng SJ (2019) Autotaxin-lysophosphatidic acid axis blockade improves inflammation by regulating Th17 cell differentiation in DSS-induced chronic colitis mice. Inflammation 42:1530\u20131541","journal-title":"Inflammation"},{"key":"7_CR178","doi-asserted-by":"crossref","first-page":"G762","DOI":"10.1152\/ajpgi.00215.2018","volume":"315","author":"P He","year":"2018","unstructured":"He P, Haque A, Lin S, Cominelli F, Yun CC (2018) Inhibition of autotaxin alleviates inflammation and increases the expression of sodium-dependent glucose cotransporter 1 and Na(+)\/H(+) exchanger 3 in SAMP1\/Fc mice. Am J Physiol Gastrointest Liver Physiol 315:G762\u2013g771","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"7_CR179","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1172\/JCI35541","volume":"119","author":"AK Singh","year":"2009","unstructured":"Singh AK, Riederer B, Krabbenhoft A, Rausch B, Bonhagen J, Lehmann U, de Jonge HR, Donowitz M, Yun C, Weinman EJ, Kocher O, Hogema BM, Seidler U (2009) Differential roles of NHERF1, NHERF2, and PDZK1 in regulating CFTR-mediated intestinal anion secretion in mice. J Clin Invest 119:540\u2013550","journal-title":"J Clin Invest"},{"key":"7_CR180","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20050421","volume":"202","author":"C Li","year":"2005","unstructured":"Li C, Dandridge KS, Di A, Marrs KL, Harris EL, Roy K, Jackson JS, Makarova NV, Fujiwara Y, Farrar PL, Nelson DJ, Tigyi GJ, Naren AP (2005) Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J Exp Med 202:975\u2013986","journal-title":"J Exp Med"},{"key":"7_CR181","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1053\/j.gastro.2007.03.038","volume":"132","author":"W Deng","year":"2007","unstructured":"Deng W, Shuyu E, Tsukahara R, Valentine WJ, Durgam G, Gududuru V, Balazs L, Manickam V, Arsura M, VanMiddlesworth L, Johnson LR, Parrill AL, Miller DD, Tigyi G (2007) The lysophosphatidic acid type 2 receptor is required for protection against radiation-induced intestinal injury. Gastroenterology 132:1834\u20131851","journal-title":"Gastroenterology"},{"key":"7_CR182","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.chembiol.2014.12.009","volume":"22","author":"R Patil","year":"2015","unstructured":"Patil R, Szabo E, Fells JI, Balogh A, Lim KG, Fujiwara Y, Norman DD, Lee SC, Balazs L, Thomas F, Patil S, Emmons-Thompson K, Boler A, Strobos J, McCool SW, Yates CR, Stabenow J, Byrne GI, Miller DD, Tigyi GJ (2015) Combined mitigation of the gastrointestinal and hematopoietic acute radiation syndromes by an LPA2 receptor-specific nonlipid agonist. Chem Biol 22:206\u2013216","journal-title":"Chem Biol"},{"key":"7_CR183","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.cellsig.2015.05.015","volume":"27","author":"A Balogh","year":"2015","unstructured":"Balogh A, Shimizu Y, Lee SC, Norman DD, Gangwar R, Bavaria M, Moon C, Shukla P, Rao R, Ray R, Naren AP, Banerjee S, Miller DD, Balazs L, Pelus L, Tigyi G (2015) The autotaxin-LPA2 GPCR axis is modulated by gamma-irradiation and facilitates DNA damage repair. Cell Signal 27:1751\u20131762","journal-title":"Cell Signal"},{"key":"7_CR184","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1194\/jlr.S091744","volume":"60","author":"GJ Tigyi","year":"2019","unstructured":"Tigyi GJ, Johnson LR, Lee SC, Norman DD, Szabo E, Balogh A, Thompson K, Boler A, McCool WS (2019) Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential. J Lipid Res 60:464\u2013474","journal-title":"J Lipid Res"},{"key":"7_CR185","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1172\/JCI79552","volume":"125","author":"P He","year":"2015","unstructured":"He P, Zhao L, Zhu L, Weinman EJ, De Giorgio R, Koval M, Srinivasan S, Yun CC (2015) Restoration of Na+\/H+ exchanger NHE3-containing macrocomplexes ameliorates diabetes-associated fluid loss. J Clin Invest 125:3519\u20133531","journal-title":"J Clin Invest"},{"key":"7_CR186","doi-asserted-by":"crossref","first-page":"G433","DOI":"10.1152\/ajpgi.00130.2018","volume":"315","author":"KA Jenkin","year":"2018","unstructured":"Jenkin KA, He P, Yun CC (2018) Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na(+)\/H(+) exchanger 3 by lysophosphatidic acid in vivo. Am J Physiol Gastrointest Liver Physiol 315:G433\u2013G442","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"7_CR187","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1053\/j.gastro.2009.09.055","volume":"138","author":"S Lin","year":"2010","unstructured":"Lin S, Yeruva S, He P, Singh AK, Zhang H, Chen M, Lamprecht G, de Jonge HR, Tse M, Donowitz M, Hogema BM, Chun J, Seidler U, Yun CC (2010) Lysophosphatidic acid stimulates the intestinal brush border Na(+)\/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF2. Gastroenterology 138:649\u2013658","journal-title":"Gastroenterology"},{"key":"7_CR188","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1248\/bpb.b15-00575","volume":"39","author":"BH Lee","year":"2016","unstructured":"Lee BH, Choi SH, Kim HJ, Jung SW, Kim HK, Nah SY (2016) Plant lysophosphatidic acids: a rich source for bioactive lysophosphatidic acids and their pharmacological applications. Biol Pharm Bull 39:156\u2013162","journal-title":"Biol Pharm Bull"},{"key":"7_CR189","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1194\/jlr.M014985","volume":"52","author":"R Dusaulcy","year":"2011","unstructured":"Dusaulcy R, Rancoule C, Gres S, Wanecq E, Colom A, Guigne C, van Meeteren LA, Moolenaar WH, Valet P, Saulnier-Blache JS (2011) Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid. J Lipid Res 52:1247\u20131255","journal-title":"J Lipid Res"},{"key":"7_CR190","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biochi.2013.04.010","volume":"96","author":"C Rancoule","year":"2014","unstructured":"Rancoule C, Dusaulcy R, Treguer K, Gres S, Attane C, Saulnier-Blache JS (2014) Involvement of autotaxin\/lysophosphatidic acid signaling in obesity and impaired glucose homeostasis. Biochimie 96:140\u2013143","journal-title":"Biochimie"},{"key":"7_CR191","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.2337\/db13-1694","volume":"63","author":"S Nishimura","year":"2014","unstructured":"Nishimura S, Nagasaki M, Okudaira S, Aoki J, Ohmori T, Ohkawa R, Nakamura K, Igarashi K, Yamashita H, Eto K, Uno K, Hayashi N, Kadowaki T, Komuro I, Yatomi Y, Nagai R (2014) ENPP2 contributes to adipose tissue expansion and insulin resistance in diet-induced obesity. Diabetes 63:4154\u20134164","journal-title":"Diabetes"},{"key":"7_CR192","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208099","volume":"14","author":"JA Brandon","year":"2019","unstructured":"Brandon JA, Kraemer M, Vandra J, Halder S, Ubele M, Morris AJ, Smyth SS (2019) Adipose-derived autotaxin regulates inflammation and steatosis associated with diet-induced obesity. PLoS One 14:e0208099","journal-title":"PLoS One"},{"key":"7_CR193","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1194\/jlr.M082008","volume":"59","author":"K D\u2019Souza","year":"2018","unstructured":"D\u2019Souza K, Nzirorera C, Cowie AM, Varghese GP, Trivedi P, Eichmann TO, Biswas D, Touaibia M, Morris AJ, Aidinis V, Kane DA, Pulinilkunnil T, Kienesberger PC (2018) Autotaxin-LPA signaling contributes to obesity-induced insulin resistance in muscle and impairs mitochondrial metabolism. J Lipid Res 59:1805\u20131817","journal-title":"J Lipid Res"},{"key":"7_CR194","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1210\/me.2011-1229","volume":"26","author":"L Federico","year":"2012","unstructured":"Federico L, Ren H, Mueller PA, Wu T, Liu S, Popovic J, Blalock EM, Sunkara M, Ovaa H, Albers HM, Mills GB, Morris AJ, Smyth SS (2012) Autotaxin and its product lysophosphatidic acid suppress brown adipose differentiation and promote diet-induced obesity in mice. Mol Endocrinol 26:786\u2013797","journal-title":"Mol Endocrinol"},{"key":"7_CR195","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/jcmm.14005","volume":"23","author":"J Weng","year":"2019","unstructured":"Weng J, Jiang S, Ding L, Xu Y, Zhu X, Jin P (2019) Autotaxin\/lysophosphatidic acid signaling mediates obesity-related cardiomyopathy in mice and human subjects. J Cell Mol Med 23:1050\u20131058","journal-title":"J Cell Mol Med"},{"key":"7_CR196","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00125-013-2891-3","volume":"56","author":"C Rancoule","year":"2013","unstructured":"Rancoule C, Attane C, Gres S, Fournel A, Dusaulcy R, Bertrand C, Vinel C, Treguer K, Prentki M, Valet P, Saulnier-Blache JS (2013) Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice. Diabetologia 56:1394\u20131402","journal-title":"Diabetologia"},{"key":"7_CR197","doi-asserted-by":"crossref","first-page":"14656","DOI":"10.1074\/jbc.M412585200","volume":"280","author":"MF Simon","year":"2005","unstructured":"Simon MF, Daviaud D, Pradere JP, Gres S, Guigne C, Wabitsch M, Chun J, Valet P, Saulnier-Blache JS (2005) Lysophosphatidic acid inhibits adipocyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma2. J Biol Chem 280:14656\u201314662","journal-title":"J Biol Chem"},{"key":"7_CR198","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF03185929","volume":"65","author":"R Dusaulcy","year":"2009","unstructured":"Dusaulcy R, Daviaud D, Pradere JP, Gres S, Valet P, Saulnier-Blache JS (2009) Altered food consumption in mice lacking lysophosphatidic acid receptor-1. J Physiol Biochem 65:345\u2013350","journal-title":"J Physiol Biochem"},{"key":"7_CR199","doi-asserted-by":"crossref","first-page":"e97293","DOI":"10.1172\/jci.insight.97293","volume":"3","author":"K Yanagida","year":"2018","unstructured":"Yanagida K, Igarashi H, Yasuda D, Kobayashi D, Ohto-Nakanishi T, Akahoshi N, Sekiba A, Toyoda T, Ishijima T, Nakai Y, Shojima N, Kubota N, Abe K, Kadowaki T, Ishii S, Shimizu T (2018) The Galpha12\/13-coupled receptor LPA4 limits proper adipose tissue expansion and remodeling in diet-induced obesity. JCI Insight 3:e97293","journal-title":"JCI Insight"},{"key":"7_CR200","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nature03505","volume":"435","author":"X Ye","year":"2005","unstructured":"Ye X, Hama K, Contos JJ, Anliker B, Inoue A, Skinner MK, Suzuki H, Amano T, Kennedy G, Arai H, Aoki J, Chun J (2005) LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing. Nature 435:104\u2013108","journal-title":"Nature"},{"key":"7_CR201","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/jb\/mvu081","volume":"157","author":"Y Sugimoto","year":"2015","unstructured":"Sugimoto Y, Inazumi T, Tsuchiya S (2015) Roles of prostaglandin receptors in female reproduction. J Biochem 157:73\u201380","journal-title":"J Biochem"},{"key":"7_CR202","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1095\/biolreprod.107.060293","volume":"77","author":"K Hama","year":"2007","unstructured":"Hama K, Aoki J, Inoue A, Endo T, Amano T, Motoki R, Kanai M, Ye X, Chun J, Matsuki N, Suzuki H, Shibasaki M, Arai H (2007) Embryo spacing and implantation timing are differentially regulated by LPA3-mediated lysophosphatidic acid signaling in mice. Biol Reprod 77:954\u2013959","journal-title":"Biol Reprod"},{"key":"7_CR203","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.15252\/embj.201696290","volume":"36","author":"S Aikawa","year":"2017","unstructured":"Aikawa S, Kano K, Inoue A, Wang J, Saigusa D, Nagamatsu T, Hirota Y, Fujii T, Tsuchiya S, Taketomi Y, Sugimoto Y, Murakami M, Arita M, Kurano M, Ikeda H, Yatomi Y, Chun J, Aoki J (2017) Autotaxin-lysophosphatidic acid-LPA3 signaling at the embryo-epithelial boundary controls decidualization pathways. EMBO J 36:2146\u20132160","journal-title":"EMBO J"},{"key":"7_CR204","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1095\/biolreprod.108.068783","volume":"79","author":"X Ye","year":"2008","unstructured":"Ye X, Skinner MK, Kennedy G, Chun J (2008) Age-dependent loss of sperm production in mice via impaired lysophosphatidic acid signaling. Biol Reprod 79:328\u2013336","journal-title":"Biol Reprod"},{"key":"7_CR205","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.1073\/pnas.97.24.13384","volume":"97","author":"JJ Contos","year":"2000","unstructured":"Contos JJ, Fukushima N, Weiner JA, Kaushal D, Chun J (2000) Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci U S A 97:13384\u201313389","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR206","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.bone.2011.04.018","volume":"49","author":"I Gennero","year":"2011","unstructured":"Gennero I, Laurencin-Dalicieux S, Conte-Auriol F, Briand-Mesange F, Laurencin D, Rue J, Beton N, Malet N, Mus M, Tokumura A, Bourin P, Vico L, Brunel G, Oreffo RO, Chun J, Salles JP (2011) Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass. Bone 49:395\u2013403","journal-title":"Bone"},{"key":"7_CR207","doi-asserted-by":"crossref","first-page":"23433","DOI":"10.1038\/srep23433","volume":"6","author":"T Nishioka","year":"2016","unstructured":"Nishioka T, Arima N, Kano K, Hama K, Itai E, Yukiura H, Kise R, Inoue A, Kim SH, Solnica-Krezel L, Moolenaar WH, Chun J, Aoki J (2016) ATX-LPA1 axis contributes to proliferation of chondrocytes by regulating fibronectin assembly leading to proper cartilage formation. Sci Rep 6:23433","journal-title":"Sci Rep"},{"key":"7_CR208","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1074\/jbc.M113.533232","volume":"289","author":"M David","year":"2014","unstructured":"David M, Machuca-Gayet I, Kikuta J, Ottewell P, Mima F, Leblanc R, Bonnelye E, Ribeiro J, Holen I, Lopez Vales R, Jurdic P, Chun J, Clezardin P, Ishii M, Peyruchaud O (2014) Lysophosphatidic acid receptor type 1 (LPA1) plays a functional role in osteoclast differentiation and bone resorption activity. J Biol Chem 289:6551\u20136564","journal-title":"J Biol Chem"},{"key":"7_CR209","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/jcb.22471","volume":"109","author":"YB Liu","year":"2010","unstructured":"Liu YB, Kharode Y, Bodine PV, Yaworsky PJ, Robinson JA, Billiard J (2010) LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4. J Cell Biochem 109:794\u2013800","journal-title":"J Cell Biochem"},{"key":"7_CR210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/bs.ctdb.2018.11.019","volume":"133","author":"Q Cong","year":"2019","unstructured":"Cong Q, Xu R, Yang Y (2019) Galphas signaling in skeletal development, homeostasis and diseases. Curr Top Dev Biol 133:281\u2013307","journal-title":"Curr Top Dev Biol"},{"key":"7_CR211","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1006\/excr.1995.1007","volume":"216","author":"GA Piazza","year":"1995","unstructured":"Piazza GA, Ritter JL, Baracka CA (1995) Lysophosphatidic acid induction of transforming growth factors alpha and beta: modulation of proliferation and differentiation in cultured human keratinocytes and mouse skin. Exp Cell Res 216:51\u201364","journal-title":"Exp Cell Res"},{"key":"7_CR212","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1046\/j.1524-475x.2000.00530.x","volume":"8","author":"JS Demoyer","year":"2000","unstructured":"Demoyer JS, Skalak TC, Durieux ME (2000) Lysophosphatidic acid enhances healing of acute cutaneous wounds in the mouse. Wound Repair Regen 8:530\u2013537","journal-title":"Wound Repair Regen"},{"key":"7_CR213","doi-asserted-by":"crossref","first-page":"R466","DOI":"10.1152\/ajpregu.2001.280.2.R466","volume":"280","author":"L Balazs","year":"2001","unstructured":"Balazs L, Okolicany J, Ferrebee M, Tolley B, Tigyi G (2001) Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo. Am J Physiol Regul Integr Comp Physiol 280:R466\u2013R472","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"7_CR214","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jid.2018.10.034","volume":"139","author":"A Sumitomo","year":"2019","unstructured":"Sumitomo A, Siriwach R, Thumkeo D, Ito K, Nakagawa R, Tanaka N, Tanabe K, Watanabe A, Kishibe M, Ishida-Yamamoto A, Honda T, Kabashima K, Aoki J, Narumiya S (2019) LPA induces keratinocyte differentiation and promotes skin barrier function through the LPAR1\/LPAR5-RHO-ROCK-SRF axis. J Invest Dermatol 139:1010\u20131022","journal-title":"J Invest Dermatol"},{"key":"7_CR215","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1468-2494.2010.00625.x","volume":"33","author":"S Yahagi","year":"2011","unstructured":"Yahagi S, Koike M, Okano Y, Masaki H (2011) Lysophospholipids improve skin moisturization by modulating of calcium-dependent cell differentiation pathway. Int J Cosmet Sci 33:251\u2013256","journal-title":"Int J Cosmet Sci"},{"key":"7_CR216","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000078632","volume":"72","author":"T Hashimoto","year":"2004","unstructured":"Hashimoto T, Ohata H, Momose K (2004) Itch-scratch responses induced by lysophosphatidic acid in mice. Pharmacology 72:51\u201356","journal-title":"Pharmacology"},{"key":"7_CR217","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000085784","volume":"75","author":"T Hashimoto","year":"2005","unstructured":"Hashimoto T, Ohata H, Momose K, Honda K (2005) Lysophosphatidic acid induces histamine release from mast cells and skin fragments. Pharmacology 75:13\u201320","journal-title":"Pharmacology"},{"key":"7_CR218","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/gerona\/glq065","volume":"65","author":"JH Rhim","year":"2010","unstructured":"Rhim JH, Jang IS, Kwon ST, Song KY, Yeo EJ, Park SC (2010) Activation of wound healing in aged rats by altering the cellular mitogenic potential. J Gerontol A Biol Sci Med Sci 65:704\u2013711","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"7_CR219","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2010.05.009","volume":"139","author":"AE Kremer","year":"2010","unstructured":"Kremer AE, Martens JJ, Kulik W, Rueff F, Kuiper EM, van Buuren HR, van Erpecum KJ, Kondrackiene J, Prieto J, Rust C, Geenes VL, Williamson C, Moolenaar WH, Beuers U, Oude Elferink RP (2010) Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 139:1008\u20131018. 1018.e1001","journal-title":"Gastroenterology"},{"key":"7_CR220","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/j.ajpath.2014.01.029","volume":"184","author":"Y Shimizu","year":"2014","unstructured":"Shimizu Y, Morikawa Y, Okudaira S, Kimoto S, Tanaka T, Aoki J, Tokumura A (2014) Potentials of the circulating pruritogenic mediator lysophosphatidic acid in development of allergic skin inflammation in mice: role of blood cell-associated lysophospholipase D activity of autotaxin. Am J Pathol 184:1593\u20131603","journal-title":"Am J Pathol"},{"key":"7_CR221","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1113\/JP273961","volume":"595","author":"H Kittaka","year":"2017","unstructured":"Kittaka H, Uchida K, Fukuta N, Tominaga M (2017) Lysophosphatidic acid-induced itch is mediated by signalling of LPA5 receptor, phospholipase D and TRPA1\/TRPV1. J Physiol 595:2681\u20132698","journal-title":"J Physiol"},{"key":"7_CR222","first-page":"e58943","volume":"151","author":"Y Yamanoi","year":"2019","unstructured":"Yamanoi Y, Kittaka H, Tominaga M (2019) Cheek injection model for simultaneous measurement of pain and itch-related behaviors. J Vis Exp 151:e58943","journal-title":"J Vis Exp"},{"key":"7_CR223","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1248\/bpb.b17-00124","volume":"40","author":"BH Lee","year":"2017","unstructured":"Lee BH, Kim HK, Jang M, Kim HJ, Choi SH, Hwang SH, Kim HC, Rhim H, Cho IH, Nah SY (2017) Effects of Gintonin-Enriched Fraction in an Atopic Dermatitis Animal Model: Involvement of Autotaxin Regulation. Biol Pharm Bull 40:1063\u20131070","journal-title":"Biol Pharm Bull"},{"key":"7_CR224","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/jid.2014.24","volume":"134","author":"M Nakao","year":"2014","unstructured":"Nakao M, Sugaya M, Suga H, Kawaguchi M, Morimura S, Kai H, Ohmatsu H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S (2014) Serum autotaxin levels correlate with pruritus in patients with atopic dermatitis. J Invest Dermatol 134:1745\u20131747","journal-title":"J Invest Dermatol"},{"key":"7_CR225","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jdermsci.2014.01.010","volume":"74","author":"Y Shimizu","year":"2014","unstructured":"Shimizu Y, Murao K, Tanaka T, Kubo Y, Tokumura A (2014) Increased lysophospholipase D activity of autotaxin in sera of patients with atopic dermatitis. J Dermatol Sci 74:162\u2013165","journal-title":"J Dermatol Sci"},{"key":"7_CR226","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.25748","volume":"56","author":"AE Kremer","year":"2012","unstructured":"Kremer AE, van Dijk R, Leckie P, Schaap FG, Kuiper EM, Mettang T, Reiners KS, Raap U, van Buuren HR, van Erpecum KJ, Davies NA, Rust C, Engert A, Jalan R, Oude Elferink RP, Beuers U (2012) Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology 56:1391\u20131400","journal-title":"Hepatology"},{"key":"7_CR227","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1126\/science.1133276","volume":"314","author":"A Kazantseva","year":"2006","unstructured":"Kazantseva A, Goltsov A, Zinchenko R, Grigorenko AP, Abrukova AV, Moliaka YK, Kirillov AG, Guo Z, Lyle S, Ginter EK, Rogaev EI (2006) Human hair growth deficiency is linked to a genetic defect in the phospholipase gene LIPH. Science 314:982\u2013985","journal-title":"Science"},{"key":"7_CR228","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00439-007-0344-0","volume":"121","author":"G Ali","year":"2007","unstructured":"Ali G, Chishti MS, Raza SI, John P, Ahmad W (2007) A mutation in the lipase H (LIPH) gene underlie autosomal recessive hypotrichosis. Hum Genet 121:319\u2013325","journal-title":"Hum Genet"},{"key":"7_CR229","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1399-0004.2008.01011.x","volume":"74","author":"M Jelani","year":"2008","unstructured":"Jelani M, Wasif N, Ali G, Chishti M, Ahmad W (2008) A novel deletion mutation in LIPH gene causes autosomal recessive hypotrichosis (LAH2). Clin Genet 74:184\u2013188","journal-title":"Clin Genet"},{"key":"7_CR230","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00403-008-0903-9","volume":"301","author":"S Nahum","year":"2009","unstructured":"Nahum S, Pasternack SM, Pforr J, Indelman M, Wollnik B, Bergman R, Nothen MM, Konig A, Khamaysi Z, Betz RC, Sprecher E (2009) A large duplication in LIPH underlies autosomal recessive hypotrichosis simplex in four Middle Eastern families. Arch Dermatol Res 301:391\u2013393","journal-title":"Arch Dermatol Res"},{"key":"7_CR231","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/jid.2008.290","volume":"129","author":"Y Shimomura","year":"2009","unstructured":"Shimomura Y, Wajid M, Petukhova L, Shapiro L, Christiano AM (2009) Mutations in the lipase H gene underlie autosomal recessive woolly hair\/hypotrichosis. J Invest Dermatol 129:622\u2013628","journal-title":"J Invest Dermatol"},{"key":"7_CR232","first-page":"602","volume":"31","author":"S Shinkuma","year":"2010","unstructured":"Shinkuma S, Akiyama M, Inoue A, Aoki J, Natsuga K, Nomura T, Arita K, Abe R, Ito K, Nakamura H, Ujiie H, Shibaki A, Suga H, Tsunemi Y, Nishie W, Shimizu H (2010) Prevalent LIPH founder mutations lead to loss of P2Y5 activation ability of PA-PLA1alpha in autosomal recessive hypotrichosis. Hum Mutat 31:602\u2013610","journal-title":"Hum Mutat"},{"key":"7_CR233","first-page":"900","volume":"38","author":"T Yoshimasu","year":"2011","unstructured":"Yoshimasu T, Kanazawa N, Kambe N, Nakamura M, Furukawa F (2011) Identification of 736T>A mutation of lipase H in Japanese siblings with autosomal recessive woolly hair. J Dermatol 38:900\u2013904","journal-title":"J Dermatol"},{"key":"7_CR234","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1468-3083.2012.04526.x","volume":"27","author":"K Tanahashi","year":"2013","unstructured":"Tanahashi K, Sugiura K, Takeichi T, Takama H, Shinkuma S, Shimizu H, Akiyama M (2013) Prevalent founder mutation c.736T>A of LIPH in autosomal recessive woolly hair of Japanese leads to variable severity of hypotrichosis in adulthood. J Eur Acad Dermatol Venereol 27:1182\u20131184","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"7_CR235","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/jid.2012.96","volume":"132","author":"S Shinkuma","year":"2012","unstructured":"Shinkuma S, Inoue A, Aoki J, Nishie W, Natsuga K, Ujiie H, Nomura T, Abe R, Akiyama M, Shimizu H (2012) The beta9 loop domain of PA-PLA1alpha has a crucial role in autosomal recessive woolly hair\/hypotrichosis. J Invest Dermatol 132:2093\u20132095","journal-title":"J Invest Dermatol"},{"key":"7_CR236","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/srep00730","volume":"2","author":"M Tariq","year":"2012","unstructured":"Tariq M, Azhar A, Baig SM, Dahl N, Klar J (2012) A novel mutation in the Lipase H gene underlies autosomal recessive hypotrichosis and woolly hair. Sci Rep 2:730","journal-title":"Sci Rep"},{"key":"7_CR237","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-4632.2012.05775.x","volume":"52","author":"K Harada","year":"2013","unstructured":"Harada K, Inozume T, Kawamura T, Shibagaki N, Kinoshita T, Deguchi N, Shimada S (2013) Two cases of autosomal recessive woolly hair with LIPH gene mutations. Int J Dermatol 52:572\u2013574","journal-title":"Int J Dermatol"},{"key":"7_CR238","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jdermsci.2013.05.001","volume":"72","author":"M Yoshizawa","year":"2013","unstructured":"Yoshizawa M, Nakamura M, Farooq M, Inoue A, Aoki J, Shimomura Y (2013) A novel mutation, c.699C>G (p.C233W), in the LIPH gene leads to a loss of the hydrolytic activity and the LPA6 activation ability of PA-PLA1alpha in autosomal recessive wooly hair\/hypotrichosis. J Dermatol Sci 72:61\u201364","journal-title":"J Dermatol Sci"},{"key":"7_CR239","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000357208","volume":"5","author":"N Matsuno","year":"2013","unstructured":"Matsuno N, Kunisada M, Kanki H, Simomura Y, Nishigori C (2013) A case of autosomal recessive woolly hair\/hypotrichosis with alternation in severity: deterioration and improvement with age. Case Rep Dermatol 5:363\u2013367","journal-title":"Case Rep Dermatol"},{"key":"7_CR240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089261","volume":"9","author":"K Tanahashi","year":"2014","unstructured":"Tanahashi K, Sugiura K, Kono M, Takama H, Hamajima N, Akiyama M (2014) Highly prevalent LIPH founder mutations causing autosomal recessive woolly hair\/hypotrichosis in Japan and the genotype\/phenotype correlations. PLoS One 9:e89261","journal-title":"PLoS One"},{"key":"7_CR241","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1111\/ajd.12157","volume":"56","author":"S Mehmood","year":"2015","unstructured":"Mehmood S, Jan A, Muhammad D, Ahmad F, Mir H, Younus M, Ali G, Ayub M, Ansar M, Ahmad W (2015) Mutations in the lipase-H gene causing autosomal recessive hypotrichosis and woolly hair. Australas J Dermatol 56:e66\u2013e70","journal-title":"Australas J Dermatol"},{"key":"7_CR242","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1684\/ejd.2014.2306","volume":"24","author":"K Hamada","year":"2014","unstructured":"Hamada K, Kubo R, Nishio D, Nakamura M (2014) A homozygous mutation, c.736T>A (p.C246S), in LIPH gene in a patient manifesting woolly hair, hypotrichosis, hearing difficulty, cleft palate and amblyopia. Eur J Dermatol 24:272\u2013273","journal-title":"Eur J Dermatol"},{"key":"7_CR243","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/1346-8138.12612","volume":"41","author":"R Hayashi","year":"2014","unstructured":"Hayashi R, Akasaka T, Ito M, Shimomura Y (2014) Compound heterozygous mutations in two distinct catalytic residues of the LIPH gene underlie autosomal recessive woolly hair in a Japanese family. J Dermatol 41:937\u2013938","journal-title":"J Dermatol"},{"key":"7_CR244","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/1346-8138.12623","volume":"41","author":"R Hayashi","year":"2014","unstructured":"Hayashi R, Inui S, Farooq M, Ito M, Shimomura Y (2014) Expression studies of a novel splice site mutation in the LIPH gene identified in a Japanese patient with autosomal recessive woolly hair. J Dermatol 41:890\u2013894","journal-title":"J Dermatol"},{"key":"7_CR245","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jdermsci.2015.03.006","volume":"78","author":"R Hayashi","year":"2015","unstructured":"Hayashi R, Inoue A, Suga Y, Aoki J, Shimomura Y (2015) Analysis of unique mutations in the LPAR6 gene identified in a Japanese family with autosomal recessive woolly hair\/hypotrichosis: Establishment of a useful assay system for LPA6. J Dermatol Sci 78:197\u2013205","journal-title":"J Dermatol Sci"},{"key":"7_CR246","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/1346-8138.12889","volume":"42","author":"T Ito","year":"2015","unstructured":"Ito T, Shimomura Y, Hayashi R, Tokura Y (2015) Identification of a novel mutation, c.686delAins18 (p.Asp229Glyfs*22), in the LIPH gene as a compound heterozygote with c.736T>A (p.Cys246Ser) in autosomal recessive woolly hair\/hypotrichosis. J Dermatol 42:752\u2013753","journal-title":"J Dermatol"},{"key":"7_CR247","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/1346-8138.12939","volume":"42","author":"MB Sleiman","year":"2015","unstructured":"Sleiman MB, Sleiman MB, Abbas O, Btadini W, Najjar T, Tofaili M, Chedraoui A, Khalil S, Kibbi AG, Kurban M (2015) Novel mutation in LIPH in a Lebanese patient with autosomal recessive woolly hair\/hypotrichosis. J Dermatol 42:822\u2013824","journal-title":"J Dermatol"},{"key":"7_CR248","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1111\/pde.12727","volume":"33","author":"S Mehmood","year":"2016","unstructured":"Mehmood S, Shah SH, Jan A, Younus M, Ahmad F, Ayub M, Ahmad W (2016) Frameshift sequence variants in the human lipase-H gene causing hypotrichosis. Pediatr Dermatol 33:e40\u2013e42","journal-title":"Pediatr Dermatol"},{"key":"7_CR249","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/bjd.14836","volume":"176","author":"M Kinoshita-Ise","year":"2017","unstructured":"Kinoshita-Ise M, Kubo A, Sasaki T, Umegaki-Arao N, Amagai M, Ohyama M (2017) Identification of factors contributing to phenotypic divergence via quantitative image analyses of autosomal recessive woolly hair\/hypotrichosis with homozygous c.736T>A LIPH mutation. Br J Dermatol 176:138\u2013144","journal-title":"Br J Dermatol"},{"key":"7_CR250","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/bjd.15070","volume":"177","author":"T Takeichi","year":"2017","unstructured":"Takeichi T, Tanahashi K, Taki T, Kono M, Sugiura K, Akiyama M (2017) Mutational analysis of 29 patients with autosomal-recessive woolly hair and hypotrichosis: LIPH mutations are extremely predominant in autosomal-recessive woolly hair and hypotrichosis in Japan. Br J Dermatol 177:290\u2013292","journal-title":"Br J Dermatol"},{"key":"7_CR251","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/1346-8138.13660","volume":"44","author":"E Itoh","year":"2017","unstructured":"Itoh E, Nakahara T, Furumura M, Furue M, Shimomura Y (2017) Case of autosomal recessive woolly hair\/hypotrichosis with atopic dermatitis. J Dermatol 44:1185\u20131186","journal-title":"J Dermatol"},{"key":"7_CR252","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/1346-8138.13373","volume":"43","author":"Y Matsuo","year":"2016","unstructured":"Matsuo Y, Tanaka A, Shimomura Y, Hide M (2016) Novel splice site mutation in LIPH identified in a Japanese patient with autosomal recessive woolly hair. J Dermatol 43:1384\u20131385","journal-title":"J Dermatol"},{"key":"7_CR253","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/cga.12226","volume":"58","author":"F Ahmad","year":"2018","unstructured":"Ahmad F, Sharif S, Furqan Ubaid M, Shah K, Khan MN, Umair M, Azeem Z, Ahmad W (2018) Novel sequence variants in the LIPH and LPAR6 genes underlies autosomal recessive woolly hair\/hypotrichosis in consanguineous families. Congenit Anom (Kyoto) 58:24\u201328","journal-title":"Congenit Anom (Kyoto)"},{"key":"7_CR254","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/mutage\/gex043","volume":"32","author":"XD Chang","year":"2017","unstructured":"Chang XD, Gu YJ, Dai S, Chen XR, Zhang CL, Zhao HS, Song QH (2017) Novel mutations in the lipase H gene lead to secretion defects of LIPH in Chinese patients with autosomal recessive woolly hair\/hypotrichosis (ARWH\/HT). Mutagenesis 32:599\u2013606","journal-title":"Mutagenesis"},{"key":"7_CR255","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/1346-8138.14257","volume":"45","author":"Y Mizukami","year":"2018","unstructured":"Mizukami Y, Hayashi R, Tsuruta D, Shimomura Y, Sugawara K (2018) Novel splice site mutation in the LIPH gene in a patient with autosomal recessive woolly hair\/hypotrichosis: case report and published work review. J Dermatol 45:613\u2013617","journal-title":"J Dermatol"},{"key":"7_CR256","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/1346-8138.14534","volume":"46","author":"N Asano","year":"2019","unstructured":"Asano N, Okita T, Yasuno S, Yamaguchi M, Kashiwagi K, Kanekura T, Shimomura Y (2019) Identification of a novel splice site mutation in the LIPH gene in a Japanese family with autosomal recessive woolly hair. J Dermatol 46:e19\u2013e20","journal-title":"J Dermatol"},{"key":"7_CR257","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.84","volume":"40","author":"SM Pasternack","year":"2008","unstructured":"Pasternack SM, von Kugelgen I, Al Aboud K, Lee YA, Ruschendorf F, Voss K, Hillmer AM, Molderings GJ, Franz T, Ramirez A, Nurnberg P, Nothen MM, Betz RC (2008) G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth. Nat Genet 40:329\u2013334","journal-title":"Nat Genet"},{"key":"7_CR258","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/ng.100","volume":"40","author":"Y Shimomura","year":"2008","unstructured":"Shimomura Y, Wajid M, Ishii Y, Shapiro L, Petukhova L, Gordon D, Christiano AM (2008) Disruption of P2RY5, an orphan G protein-coupled receptor, underlies autosomal recessive woolly hair. Nat Genet 40:335\u2013339","journal-title":"Nat Genet"},{"key":"7_CR259","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00439-008-0507-7","volume":"123","author":"Z Azeem","year":"2008","unstructured":"Azeem Z, Jelani M, Naz G, Tariq M, Wasif N, Kamran-Ul-Hassan Naqvi S, Ayub M, Yasinzai M, Amin-Ud-Din M, Wali A, Ali G, Chishti MS, Ahmad W (2008) Novel mutations in G protein-coupled receptor gene (P2RY5) in families with autosomal recessive hypotrichosis (LAH3). Hum Genet 123:515\u2013519","journal-title":"Hum Genet"},{"key":"7_CR260","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygeno.2008.06.009","volume":"92","author":"L Petukhova","year":"2008","unstructured":"Petukhova L, Sousa EC Jr, Martinez-Mir A, Vitebsky A, Dos Santos LG, Shapiro L, Haynes C, Gordon D, Shimomura Y, Christiano AM (2008) Genome-wide linkage analysis of an autosomal recessive hypotrichosis identifies a novel P2RY5 mutation. Genomics 92:273\u2013278","journal-title":"Genomics"},{"key":"7_CR261","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0625.2008.00788.x","volume":"18","author":"Y Shimomura","year":"2009","unstructured":"Shimomura Y, Garzon MC, Kristal L, Shapiro L, Christiano AM (2009) Autosomal recessive woolly hair with hypotrichosis caused by a novel homozygous mutation in the P2RY5 gene. Exp Dermatol 18:218\u2013221","journal-title":"Exp Dermatol"},{"key":"7_CR262","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/j.1365-2133.2009.09046.x","volume":"160","author":"M Tariq","year":"2009","unstructured":"Tariq M, Ayub M, Jelani M, Basit S, Naz G, Wasif N, Raza SI, Naveed AK, Khan SU, Azeem Z, Yasinzai M, Wali A, Ali G, Chishti MS, Ahmad W (2009) Mutations in the P2RY5 gene underlie autosomal recessive hypotrichosis in 13 Pakistani families. Br J Dermatol 160:1006\u20131010","journal-title":"Br J Dermatol"},{"key":"7_CR263","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00403-009-0971-5","volume":"301","author":"SM Pasternack","year":"2009","unstructured":"Pasternack SM, Murugusundram S, Eigelshoven S, Muller M, Kruse R, Lehmann P, Betz RC (2009) Novel mutations in the P2RY5 gene in one Turkish and two Indian patients presenting with hypotrichosis and woolly hair. Arch Dermatol Res 301:621\u2013624","journal-title":"Arch Dermatol Res"},{"key":"7_CR264","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jdermsci.2009.10.015","volume":"57","author":"M Kurban","year":"2010","unstructured":"Kurban M, Ghosn S, Abbas O, Shimomura Y, Christiano A (2010) A missense mutation in the P2RY5 gene leading to autosomal recessive woolly hair in a Syrian patient. J Dermatol Sci 57:132\u2013134","journal-title":"J Dermatol Sci"},{"key":"7_CR265","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1468-3083.2009.03514.x","volume":"24","author":"L Horev","year":"2010","unstructured":"Horev L, Saad-Edin B, Ingber A, Zlotogorski A (2010) A novel deletion mutation in P2RY5\/LPA(6) gene cause autosomal recessive woolly hair with hypotrichosis. J Eur Acad Dermatol Venereol 24:858\u2013859","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"7_CR266","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2230.2010.03944.x","volume":"36","author":"S Nahum","year":"2011","unstructured":"Nahum S, Morice-Picard F, Taieb A, Sprecher E (2011) A novel mutation in LPAR6 causes autosomal recessive hypotrichosis of the scalp. Clin Exp Dermatol 36:188\u2013194","journal-title":"Clin Exp Dermatol"},{"key":"7_CR267","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1365-2230.2011.04014.x","volume":"36","author":"S Khan","year":"2011","unstructured":"Khan S, Habib R, Mir H, Umme K, Naz G, Ayub M, Shafique S, Yamin T, Ali N, Basit S, Wasif N, Naqvi SK-U-H, Ali G, Wali A, Ansar M, Ahmad W (2011) Mutations in the LPAR6 and LIPH genes underlie autosomal recessive hypotrichosis\/woolly hair in 17 consanguineous families from Pakistan. Clin Exp Dermatol 36:652\u2013654","journal-title":"Clin Exp Dermatol"},{"key":"7_CR268","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1468-3083.2012.04472.x","volume":"27","author":"M Kurban","year":"2013","unstructured":"Kurban M, Wajid M, Shimomura Y, Christiano AM (2013) Mutations in LPAR6\/P2RY5 and LIPH are associated with woolly hair and\/or hypotrichosis. J Eur Acad Dermatol Venereol 27:545\u2013549","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"7_CR269","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-0625.2012.01504.x","volume":"21","author":"H Mahmoudi","year":"2012","unstructured":"Mahmoudi H, Tug E, Parlak AH, Atasoy HI, Ludwig M, Polat M, Pasternack SM, Betz RC (2012) Identification of an Alu-mediated 12.2-kb deletion of the complete LPAR6 (P2RY5) gene in a Turkish family with hypotrichosis and woolly hair. Exp Dermatol 21:469\u2013471","journal-title":"Exp Dermatol"},{"key":"7_CR270","first-page":"796","volume":"38","author":"LH Liu","year":"2013","unstructured":"Liu LH, Chen G, Wang JW, Liu SX, Wang JB, Zhou FS, Zhu J, Sun LD, Gao M, Wang PG, Yang S, Zhang XJ (2013) A novel deletion mutation in the LPAR6 gene underlies autosomal recessive woolly hair with hypotrichosis. Clin Exp Dermatol 38:796\u2013798","journal-title":"Clin Exp Dermatol"},{"key":"7_CR271","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/ijd.14480","volume":"58","author":"GM Khan","year":"2019","unstructured":"Khan GM, Hassan N, Khan N, Humayun M, Khan K, Khaliq S, Rehman FU, Ahmed S, Shah K, Khan SA, Muhammad N, Wali A, Khan S, Basit S, Ayub M (2019) Biallelic mutations in the LPAR6 gene causing autosomal recessive wooly hair\/hypotrichosis phenotype in five Pakistani families. Int J Dermatol 58:946\u2013952","journal-title":"Int J Dermatol"},{"key":"7_CR272","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019281","volume":"6","author":"M Diribarne","year":"2011","unstructured":"Diribarne M, Mata X, Chantry-Darmon C, Vaiman A, Auvinet G, Bouet S, Deretz S, Cribiu EP, de Rochambeau H, Allain D, Guerin G (2011) A deletion in exon 9 of the LIPH gene is responsible for the rex hair coat phenotype in rabbits (Oryctolagus cuniculus). PLoS One 6:e19281","journal-title":"PLoS One"},{"key":"7_CR273","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067105","volume":"8","author":"B Gandolfi","year":"2013","unstructured":"Gandolfi B, Alhaddad H, Affolter VK, Brockman J, Haggstrom J, Joslin SE, Koehne AL, Mullikin JC, Outerbridge CA, Warren WC, Lyons LA (2013) To the root of the curl: a signature of a recent selective sweep identifies a mutation that defines the Cornish Rex cat breed. PLoS One 8:e67105","journal-title":"PLoS One"},{"key":"7_CR274","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1038\/jid.2013.140","volume":"133","author":"L Grisanti","year":"2013","unstructured":"Grisanti L, Rezza A, Clavel C, Sennett R, Rendl M (2013) Enpp2\/Autotaxin in dermal papilla precursors is dispensable for hair follicle morphogenesis. J Invest Dermatol 133:2332\u20132339","journal-title":"J Invest Dermatol"},{"key":"7_CR275","doi-asserted-by":"crossref","first-page":"27050","DOI":"10.1038\/srep27050","volume":"6","author":"KH Lin","year":"2016","unstructured":"Lin KH, Ho YH, Chiang JC, Li MW, Lin SH, Chen WM, Chiang CL, Lin YN, Yang YJ, Chen CN, Lu J, Huang CJ, Tigyi G, Yao CL, Lee H (2016) Pharmacological activation of lysophosphatidic acid receptors regulates erythropoiesis. Sci Rep 6:27050","journal-title":"Sci Rep"},{"key":"7_CR276","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1667\/RR13830.1","volume":"183","author":"W Deng","year":"2015","unstructured":"Deng W, Kimura Y, Gududuru V, Wu W, Balogh A, Szabo E, Thompson KE, Yates CR, Balazs L, Johnson LR, Miller DD, Strobos J, McCool WS, Tigyi GJ (2015) Mitigation of the hematopoietic and gastrointestinal acute radiation syndrome by octadecenyl thiophosphate, a small molecule mimic of lysophosphatidic acid. Radiat Res 183:465\u2013475","journal-title":"Radiat Res"},{"key":"7_CR277","doi-asserted-by":"crossref","first-page":"11410","DOI":"10.1038\/srep11410","volume":"5","author":"H Igarashi","year":"2015","unstructured":"Igarashi H, Akahoshi N, Ohto-Nakanishi T, Yasuda D, Ishii S (2015) The lysophosphatidic acid receptor LPA4 regulates hematopoiesis-supporting activity of bone marrow stromal cells. Sci Rep 5:11410","journal-title":"Sci Rep"},{"key":"7_CR278","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/ni1573","volume":"9","author":"H Kanda","year":"2008","unstructured":"Kanda H, Newton R, Klein R, Morita Y, Gunn MD, Rosen SD (2008) Autotaxin, an ectoenzyme that produces lysophosphatidic acid, promotes the entry of lymphocytes into secondary lymphoid organs. Nat Immunol 9:415\u2013423","journal-title":"Nat Immunol"},{"key":"7_CR279","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2353\/ajpath.2008.071153","volume":"173","author":"T Nakasaki","year":"2008","unstructured":"Nakasaki T, Tanaka T, Okudaira S, Hirosawa M, Umemoto E, Otani K, Jin S, Bai Z, Hayasaka H, Fukui Y, Aozasa K, Fujita N, Tsuruo T, Ozono K, Aoki J, Miyasaka M (2008) Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions. Am J Pathol 173:1566\u20131576","journal-title":"Am J Pathol"},{"key":"7_CR280","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.4049\/jimmunol.1202025","volume":"190","author":"Z Bai","year":"2013","unstructured":"Bai Z, Cai L, Umemoto E, Takeda A, Tohya K, Komai Y, Veeraveedu PT, Hata E, Sugiura Y, Kubo A, Suematsu M, Hayasaka H, Okudaira S, Aoki J, Tanaka T, Albers HM, Ovaa H, Miyasaka M (2013) Constitutive lymphocyte transmigration across the basal lamina of high endothelial venules is regulated by the autotaxin\/lysophosphatidic acid axis. J Immunol 190:2036\u20132048","journal-title":"J Immunol"},{"key":"7_CR281","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4049\/jimmunol.1400565","volume":"193","author":"T Katakai","year":"2014","unstructured":"Katakai T, Kondo N, Ueda Y, Kinashi T (2014) Autotaxin produced by stromal cells promotes LFA-1-independent and Rho-dependent interstitial T cell motility in the lymph node paracortex. J Immunol 193:617\u2013626","journal-title":"J Immunol"},{"key":"7_CR282","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fimmu.2016.00194","volume":"7","author":"T Katakai","year":"2016","unstructured":"Katakai T, Kinashi T (2016) Microenvironmental control of high-speed interstitial T cell migration in the lymph node. Front Immunol 7:194","journal-title":"Front Immunol"},{"key":"7_CR283","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40478-017-0446-4","volume":"5","author":"K Schmitz","year":"2017","unstructured":"Schmitz K, Brunkhorst R, de Bruin N, Mayer CA, Haussler A, Ferreiros N, Schiffmann S, Parnham MJ, Tunaru S, Chun J, Offermanns S, Foerch C, Scholich K, Vogt J, Wicker S, Lotsch J, Geisslinger G, Tegeder I (2017) Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis. Acta Neuropathol Commun 5:42","journal-title":"Acta Neuropathol Commun"},{"key":"7_CR284","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1158\/2326-6066.CIR-13-0043-T","volume":"1","author":"SK Oda","year":"2013","unstructured":"Oda SK, Strauch P, Fujiwara Y, Al-Shami A, Oravecz T, Tigyi G, Pelanda R, Torres RM (2013) Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression. Cancer Immunol Res 1:245\u2013255","journal-title":"Cancer Immunol Res"},{"key":"7_CR285","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3389\/fimmu.2019.01159","volume":"10","author":"D Mathew","year":"2019","unstructured":"Mathew D, Kremer KN, Strauch P, Tigyi G, Pelanda R, Torres RM (2019) LPA5 is an inhibitory receptor that suppresses CD8 T-Cell cytotoxic function via disruption of early TCR signaling. Front Immunol 10:1159","journal-title":"Front Immunol"},{"key":"7_CR286","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4049\/jimmunol.1300429","volume":"193","author":"J Hu","year":"2014","unstructured":"Hu J, Oda SK, Shotts K, Donovan EE, Strauch P, Pujanauski LM, Victorino F, Al-Shami A, Fujiwara Y, Tigyi G, Oravecz T, Pelanda R, Torres RM (2014) Lysophosphatidic acid receptor 5 inhibits B cell antigen receptor signaling and antibody response. J Immunol 193:85\u201395","journal-title":"J Immunol"},{"key":"7_CR287","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/279250a0","volume":"279","author":"TW Martin","year":"1979","unstructured":"Martin TW, Lagunoff D (1979) Interactions of lysophospholipids and mast cells. Nature 279:250\u2013252","journal-title":"Nature"},{"key":"7_CR288","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1476-5381.1988.tb10322.x","volume":"93","author":"HW Chang","year":"1988","unstructured":"Chang HW, Inoue K, Bruni A, Boarato E, Toffano G (1988) Stereoselective effects of lysophosphatidylserine in rodents. Br J Pharmacol 93:647\u2013653","journal-title":"Br J Pharmacol"},{"key":"7_CR289","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.bbrc.2006.01.069","volume":"341","author":"T Sugo","year":"2006","unstructured":"Sugo T, Tachimoto H, Chikatsu T, Murakami Y, Kikukawa Y, Sato S, Kikuchi K, Nagi T, Harada M, Ogi K, Ebisawa M, Mori M (2006) Identification of a lysophosphatidylserine receptor on mast cells. Biochem Biophys Res Commun 341:1078\u20131087","journal-title":"Biochem Biophys Res Commun"},{"key":"7_CR290","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1074\/jbc.M110.196659","volume":"286","author":"I Liebscher","year":"2011","unstructured":"Liebscher I, Muller U, Teupser D, Engemaier E, Engel KM, Ritscher L, Thor D, Sangkuhl K, Ricken A, Wurm A, Piehler D, Schmutzler S, Fuhrmann H, Albert FW, Reichenbach A, Thiery J, Schoneberg T, Schulz A (2011) Altered immune response in mice deficient for the G protein-coupled receptor GPR34. J Biol Chem 286:2101\u20132110","journal-title":"J Biol Chem"},{"key":"7_CR291","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nmeth.2172","volume":"9","author":"A Inoue","year":"2012","unstructured":"Inoue A, Ishiguro J, Kitamura H, Arima N, Okutani M, Shuto A, Higashiyama S, Ohwada T, Arai H, Makide K, Aoki J (2012) TGFalpha shedding assay: an accurate and versatile method for detecting GPCR activation. Nat Methods 9:1021\u20131029","journal-title":"Nat Methods"},{"key":"7_CR292","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/jb\/mvu060","volume":"157","author":"A Uwamizu","year":"2015","unstructured":"Uwamizu A, Inoue A, Suzuki K, Okudaira M, Shuto A, Shinjo Y, Ishiguro J, Makide K, Ikubo M, Nakamura S, Jung S, Sayama M, Otani Y, Ohwada T, Aoki J (2015) Lysophosphatidylserine analogues differentially activate three LysoPS receptors. J Biochem 157:151\u2013160","journal-title":"J Biochem"},{"key":"7_CR293","first-page":"346","volume":"8","author":"T Kishi","year":"2016","unstructured":"Kishi T, Kawana H, Sayama M, Makide K, Inoue A, Otani Y, Ohwada T, Aoki J (2016) Identification of lysophosphatidylthreonine with an aromatic fatty acid surrogate as a potent inducer of mast cell degranulation. Biochem Biophys Rep 8:346\u2013351","journal-title":"Biochem Biophys Rep"},{"key":"7_CR294","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1074\/jbc.272.4.2192","volume":"272","author":"T Sato","year":"1997","unstructured":"Sato T, Aoki J, Nagai Y, Dohmae N, Takio K, Doi T, Arai H, Inoue K (1997) Serine phospholipid-specific phospholipase A that is secreted from activated platelets. A new member of the lipase family. J Biol Chem 272:2192\u20132198","journal-title":"J Biol Chem"},{"key":"7_CR295","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bbacli.2015.08.003","volume":"4","author":"M Kurano","year":"2015","unstructured":"Kurano M, Dohi T, Nojiri T, Kobayashi T, Hirowatari Y, Inoue A, Kano K, Matsumoto H, Igarashi K, Nishikawa M, Miyauchi K, Daida H, Ikeda H, Aoki J, Yatomi Y (2015) Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids. BBA Clin 4:92\u201398","journal-title":"BBA Clin"},{"key":"7_CR296","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1194\/jlr.P072090","volume":"58","author":"S Emoto","year":"2017","unstructured":"Emoto S, Kurano M, Kano K, Matsusaki K, Yamashita H, Nishikawa M, Igarashi K, Ikeda H, Aoki J, Kitayama J, Yatomi Y (2017) Analysis of glycero-lysophospholipids in gastric cancerous ascites. J Lipid Res 58:763\u2013771","journal-title":"J Lipid Res"},{"key":"7_CR297","doi-asserted-by":"crossref","first-page":"29664","DOI":"10.1074\/jbc.M104597200","volume":"276","author":"H Hosono","year":"2001","unstructured":"Hosono H, Aoki J, Nagai Y, Bandoh K, Ishida M, Taguchi R, Arai H, Inoue K (2001) Phosphatidylserine-specific phospholipase A1 stimulates histamine release from rat peritoneal mast cells through production of 2-acyl-1-lysophosphatidylserine. J Biol Chem 276:29664\u201329670","journal-title":"J Biol Chem"},{"key":"7_CR298","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nchembio.1721","volume":"11","author":"SS Kamat","year":"2015","unstructured":"Kamat SS, Camara K, Parsons WH, Chen DH, Dix MM, Bird TD, Howell AR, Cravatt BF (2015) Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay. Nat Chem Biol 11:164\u2013171","journal-title":"Nat Chem Biol"},{"key":"7_CR299","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12974-019-1458-8","volume":"16","author":"A Sayo","year":"2019","unstructured":"Sayo A, Konishi H, Kobayashi M, Kano K, Kobayashi H, Hibi H, Aoki J, Kiyama H (2019) GPR34 in spinal microglia exacerbates neuropathic pain in mice. J Neuroinflammation 16:82","journal-title":"J Neuroinflammation"},{"key":"7_CR300","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1073\/pnas.1217121110","volume":"110","author":"JL Blankman","year":"2013","unstructured":"Blankman JL, Long JZ, Trauger SA, Siuzdak G, Cravatt BF (2013) ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC. Proc Natl Acad Sci U S A 110:1500\u20131505","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR301","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/glia.22744","volume":"63","author":"J Preissler","year":"2015","unstructured":"Preissler J, Grosche A, Lede V, Le Duc D, Krugel K, Matyash V, Szulzewsky F, Kallendrusch S, Immig K, Kettenmann H, Bechmann I, Schoneberg T, Schulz A (2015) Altered microglial phagocytosis in GPR34-deficient mice. Glia 63:206\u2013215","journal-title":"Glia"},{"key":"7_CR302","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pharmthera.2018.04.008","volume":"189","author":"T Schoneberg","year":"2018","unstructured":"Schoneberg T, Meister J, Knierim AB, Schulz A (2018) The G protein-coupled receptor GPR34\u00a0\u2013 The past 20 years of a grownup. Pharmacol Ther 189:71\u201388","journal-title":"Pharmacol Ther"},{"key":"7_CR303","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1084\/jem.20141827","volume":"212","author":"MJ Barnes","year":"2015","unstructured":"Barnes MJ, Li CM, Xu Y, An J, Huang Y, Cyster JG (2015) The lysophosphatidylserine receptor GPR174 constrains regulatory T cell development and function. J Exp Med 212:1011\u20131020","journal-title":"J Exp Med"},{"key":"7_CR304","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbrc.2017.10.028","volume":"494","author":"Y Shinjo","year":"2017","unstructured":"Shinjo Y, Makide K, Satoh K, Fukami F, Inoue A, Kano K, Otani Y, Ohwada T, Aoki J (2017) Lysophosphatidylserine suppresses IL-2 production in CD4 T cells through LPS3\/GPR174. Biochem Biophys Res Commun 494:332\u2013338","journal-title":"Biochem Biophys Res Commun"},{"key":"7_CR305","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/imcb.12025","volume":"96","author":"MJ Barnes","year":"2018","unstructured":"Barnes MJ, Cyster JG (2018) Lysophosphatidylserine suppression of T-cell activation via GPR174 requires Galphas proteins. Immunol Cell Biol 96:439\u2013445","journal-title":"Immunol Cell Biol"},{"key":"7_CR306","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41419-019-1462-z","volume":"10","author":"D Qiu","year":"2019","unstructured":"Qiu D, Chu X, Hua L, Yang Y, Li K, Han Y, Yin J, Zhu M, Mu S, Sun Z, Tong C, Song Z (2019) Gpr174-deficient regulatory T cells decrease cytokine storm in septic mice. Cell Death Dis 10:233","journal-title":"Cell Death Dis"},{"key":"7_CR307","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jmedgenet-2013-101595","volume":"50","author":"X Chu","year":"2013","unstructured":"Chu X, Shen M, Xie F, Miao XJ, Shou WH, Liu L, Yang PP, Bai YN, Zhang KY, Yang L, Hua Q, Liu WD, Dong Y, Wang HF, Shi JX, Wang Y, Song HD, Chen SJ, Chen Z, Huang W (2013) An X chromosome-wide association analysis identifies variants in GPR174 as a risk factor for Graves\u2019 disease. J Med Genet 50:479\u2013485","journal-title":"J Med Genet"},{"key":"7_CR308","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/tan.12259","volume":"83","author":"K Szymanski","year":"2014","unstructured":"Szymanski K, Miskiewicz P, Pirko K, Jurecka-Lubieniecka B, Kula D, Hasse-Lazar K, Krajewski P, Bednarczuk T, Ploski R (2014) rs3827440, a nonsynonymous single nucleotide polymorphism within GPR174 gene in X chromosome, is associated with Graves\u2019 disease in Polish Caucasian population. Tissue Antigens 83:41\u201344","journal-title":"Tissue Antigens"},{"key":"7_CR309","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1093\/hmg\/ddt183","volume":"22","author":"SX Zhao","year":"2013","unstructured":"Zhao SX, Xue LQ, Liu W, Gu ZH, Pan CM, Yang SY, Zhan M, Wang HN, Liang J, Gao GQ, Zhang XM, Yuan GY, Li CG, Du WH, Liu BL, Liu LB, Chen G, Su Q, Peng YD, Zhao JJ, Ning G, Huang W, Liang L, Qi L, Chen SJ, Chen Z, Chen JL, Song HD (2013) Robust evidence for five new Graves\u2019 disease risk loci from a staged genome-wide association analysis. Hum Mol Genet 22:3347\u20133362","journal-title":"Hum Mol Genet"},{"key":"7_CR310","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature12873","volume":"506","author":"Y Okada","year":"2014","unstructured":"Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, Graham RR, Manoharan A, Ortmann W, Bhangale T, Denny JC, Carroll RJ, Eyler AE, Greenberg JD, Kremer JM, Pappas DA, Jiang L, Yin J, Ye L, Su DF, Yang J, Xie G, Keystone E, Westra HJ, Esko T, Metspalu A, Zhou X, Gupta N, Mirel D, Stahl EA, Diogo D, Cui J, Liao K, Guo MH, Myouzen K, Kawaguchi T, Coenen MJ, van Riel PL, van de Laar MA, Guchelaar HJ, Huizinga TW, Dieude P, Mariette X, Bridges SL Jr, Zhernakova A, Toes RE, Tak PP, Miceli-Richard C, Bang SY, Lee HS, Martin J, Gonzalez-Gay MA, Rodriguez-Rodriguez L, Rantapaa-Dahlqvist S, Arlestig L, Choi HK, Kamatani Y, Galan P, Lathrop M, Eyre S, Bowes J, Barton A, de Vries N, Moreland LW, Criswell LA, Karlson EW, Taniguchi A, Yamada R, Kubo M, Liu JS, Bae SC, Worthington J, Padyukov L, Klareskog L, Gregersen PK, Raychaudhuri S, Stranger BE, De Jager PL, Franke L, Visscher PM, Brown MA, Yamanaka H, Mimori T, Takahashi A, Xu H, Behrens TW, Siminovitch KA, Momohara S, Matsuda F, Yamamoto K, Plenge RM (2014) Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506:376\u2013381","journal-title":"Nature"},{"key":"7_CR311","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(98)00277-0","volume":"64","author":"M Sawzdargo","year":"1999","unstructured":"Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH, George SR, O\u2019Dowd BF (1999) Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res 64:193\u2013198","journal-title":"Brain Res Mol Brain Res"},{"key":"7_CR312","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1747-0285.2006.00370.x","volume":"67","author":"F Petitet","year":"2006","unstructured":"Petitet F, Donlan M, Michel A (2006) GPR55 as a new cannabinoid receptor: still a long way to prove it. Chem Biol Drug Des 67:252\u2013253","journal-title":"Chem Biol Drug Des"},{"key":"7_CR313","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1515\/jbcpp-2015-0080","volume":"27","author":"H Yang","year":"2016","unstructured":"Yang H, Zhou J, Lehmann C (2016) GPR55\u00a0\u2013 a putative \u201ctype 3\u201d cannabinoid receptor in inflammation. J Basic Clin Physiol Pharmacol 27:297\u2013302","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"7_CR314","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bbrc.2007.08.078","volume":"362","author":"S Oka","year":"2007","unstructured":"Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T (2007) Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun 362:928\u2013934","journal-title":"Biochem Biophys Res Commun"},{"key":"7_CR315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvn136","volume":"145","author":"S Oka","year":"2009","unstructured":"Oka S, Toshida T, Maruyama K, Nakajima K, Yamashita A, Sugiura T (2009) 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55. J Biochem 145:13\u201320","journal-title":"J Biochem"},{"key":"7_CR316","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1111\/bph.12678","volume":"171","author":"Y Kihara","year":"2014","unstructured":"Kihara Y, Maceyka M, Spiegel S, Chun J (2014) Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br J Pharmacol 171:3575\u20133594","journal-title":"Br J Pharmacol"},{"key":"7_CR317","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1476-5381.2010.00744.x","volume":"161","author":"A Bondarenko","year":"2010","unstructured":"Bondarenko A, Waldeck-Weiermair M, Naghdi S, Poteser M, Malli R, Graier WF (2010) GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells. Br J Pharmacol 161:308\u2013320","journal-title":"Br J Pharmacol"},{"key":"7_CR318","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.aab3516","volume":"349","author":"AT Guy","year":"2015","unstructured":"Guy AT, Nagatsuka Y, Ooashi N, Inoue M, Nakata A, Greimel P, Inoue A, Nabetani T, Murayama A, Ohta K, Ito Y, Aoki J, Hirabayashi Y, Kamiguchi H (2015) Neuronal development. Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord. Science 349:974\u2013977","journal-title":"Science"},{"key":"7_CR319","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.bbalip.2010.03.012","volume":"1801","author":"A Yamashita","year":"2010","unstructured":"Yamashita A, Kumazawa T, Koga H, Suzuki N, Oka S, Sugiura T (2010) Generation of lysophosphatidylinositol by DDHD domain containing 1 (DDHD1): possible involvement of phospholipase D\/phosphatidic acid in the activation of DDHD1. Biochim Biophys Acta 1801:711\u2013720","journal-title":"Biochim Biophys Acta"},{"key":"7_CR320","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1021\/acs.biochem.8b00810","volume":"57","author":"JM Inloes","year":"2018","unstructured":"Inloes JM, Jing H, Cravatt BF (2018) The spastic paraplegia-associated phospholipase DDHD1 is a primary brain phosphatidylinositol lipase. Biochemistry 57:5759\u20135767","journal-title":"Biochemistry"},{"key":"7_CR321","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2008.04.006","volume":"139","author":"PC Staton","year":"2008","unstructured":"Staton PC, Hatcher JP, Walker DJ, Morrison AD, Shapland EM, Hughes JP, Chong E, Mander PK, Green PJ, Billinton A, Fulleylove M, Lancaster HC, Smith JC, Bailey LT, Wise A, Brown AJ, Richardson JC, Chessell IP (2008) The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain 139:225\u2013236","journal-title":"Pain"},{"key":"7_CR322","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.pain.2013.08.019","volume":"154","author":"V Gangadharan","year":"2013","unstructured":"Gangadharan V, Selvaraj D, Kurejova M, Njoo C, Gritsch S, Skoricova D, Horstmann H, Offermanns S, Brown AJ, Kuner T, Tappe-Theodor A, Kuner R (2013) A novel biological role for the phospholipid lysophosphatidylinositol in nociceptive sensitization via activation of diverse G-protein signalling pathways in sensory nerves in vivo. Pain 154:2801\u20132812","journal-title":"Pain"},{"key":"7_CR323","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/ibd.21538","volume":"17","author":"R Schicho","year":"2011","unstructured":"Schicho R, Bashashati M, Bawa M, McHugh D, Saur D, Hu HM, Zimmer A, Lutz B, Mackie K, Bradshaw HB, McCafferty DM, Sharkey KA, Storr M (2011) The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment. Inflamm Bowel Dis 17:1651\u20131664","journal-title":"Inflamm Bowel Dis"},{"key":"7_CR324","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000339076","volume":"90","author":"GR Ross","year":"2012","unstructured":"Ross GR, Lichtman A, Dewey WL, Akbarali HI (2012) Evidence for the putative cannabinoid receptor (GPR55)-mediated inhibitory effects on intestinal contractility in mice. Pharmacology 90:55\u201365","journal-title":"Pharmacology"},{"key":"7_CR325","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuropharm.2013.03.029","volume":"71","author":"K Li","year":"2013","unstructured":"Li K, Fichna J, Schicho R, Saur D, Bashashati M, Mackie K, Li Y, Zimmer A, Goke B, Sharkey KA, Storr M (2013) A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice. Neuropharmacology 71:255\u2013263","journal-title":"Neuropharmacology"},{"key":"7_CR326","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/nmo.12639","volume":"27","author":"A Stancic","year":"2015","unstructured":"Stancic A, Jandl K, Hasenohrl C, Reichmann F, Marsche G, Schuligoi R, Heinemann A, Storr M, Schicho R (2015) The GPR55 antagonist CID16020046 protects against intestinal inflammation. Neurogastroenterol Motil 27:1432\u20131445","journal-title":"Neurogastroenterol Motil"},{"key":"7_CR327","volume":"9","author":"SK Walsh","year":"2014","unstructured":"Walsh SK, Hector EE, Andreasson AC, Jonsson-Rylander AC, Wainwright CL (2014) GPR55 deletion in mice leads to age-related ventricular dysfunction and impaired adrenoceptor-mediated inotropic responses. PLoS One 9:e108999","journal-title":"PLoS One"},{"key":"7_CR328","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1161\/ATVBAHA.118.311185","volume":"38","author":"P Rinne","year":"2018","unstructured":"Rinne P, Guillamat-Prats R, Rami M, Bindila L, Ring L, Lyytikainen LP, Raitoharju E, Oksala N, Lehtimaki T, Weber C, van der Vorst EPC, Steffens S (2018) Palmitoylethanolamide promotes a proresolving macrophage phenotype and attenuates atherosclerotic plaque formation. Arterioscler Thromb Vasc Biol 38:2562\u20132575","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7_CR329","doi-asserted-by":"crossref","first-page":"e00487","DOI":"10.1002\/prp2.487","volume":"7","author":"OJ Robertson-Gray","year":"2019","unstructured":"Robertson-Gray OJ, Walsh SK, Ryberg E, Jonsson-Rylander AC, Lipina C, Wainwright CL (2019) l-alpha-Lysophosphatidylinositol (LPI) aggravates myocardial ischemia\/reperfusion injury via a GPR55\/ROCK-dependent pathway. Pharmacol Res Perspect 7:e00487","journal-title":"Pharmacol Res Perspect"},{"key":"7_CR330","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1530\/JOE-11-0166","volume":"211","author":"SY Romero-Zerbo","year":"2011","unstructured":"Romero-Zerbo SY, Rafacho A, Diaz-Arteaga A, Suarez J, Quesada I, Imbernon M, Ross RA, Dieguez C, Rodriguez de Fonseca F, Nogueiras R, Nadal A, Bermudez-Silva FJ (2011) A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans. J Endocrinol 211:177\u2013185","journal-title":"J Endocrinol"},{"key":"7_CR331","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/dom.12780","volume":"18","author":"B Liu","year":"2016","unstructured":"Liu B, Song S, Ruz-Maldonado I, Pingitore A, Huang GC, Baker D, Jones PM, Persaud SJ (2016) GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans. Diabetes Obes Metab 18:1263\u20131273","journal-title":"Diabetes Obes Metab"},{"key":"7_CR332","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/dom.13180","volume":"20","author":"I Ruz-Maldonado","year":"2018","unstructured":"Ruz-Maldonado I, Pingitore A, Liu B, Atanes P, Huang GC, Baker D, Alonso FJ, Bermudez-Silva FJ, Persaud SJ (2018) LH-21 and abnormal cannabidiol improve beta-cell function in isolated human and mouse islets through GPR55-dependent and -independent signalling. Diabetes Obes Metab 20:930\u2013942","journal-title":"Diabetes Obes Metab"},{"key":"7_CR333","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1038\/onc.2012.278","volume":"32","author":"E Perez-Gomez","year":"2013","unstructured":"Perez-Gomez E, Andradas C, Flores JM, Quintanilla M, Paramio JM, Guzman M, Sanchez C (2013) The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas. Oncogene 32:2534\u20132542","journal-title":"Oncogene"},{"key":"7_CR334","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.31030","volume":"142","author":"C Hasenoehrl","year":"2018","unstructured":"Hasenoehrl C, Feuersinger D, Sturm EM, Barnthaler T, Heitzer E, Graf R, Grill M, Pichler M, Beck S, Butcher L, Thomas D, Ferreiros N, Schuligoi R, Schweiger C, Haybaeck J, Schicho R (2018) G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1. Int J Cancer 142:121\u2013132","journal-title":"Int J Cancer"},{"key":"7_CR335","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1038\/s41388-018-0390-1","volume":"37","author":"R Ferro","year":"2018","unstructured":"Ferro R, Adamska A, Lattanzio R, Mavrommati I, Edling CE, Arifin SA, Fyffe CA, Sala G, Sacchetto L, Chiorino G, De Laurenzi V, Piantelli M, Sansom OJ, Maffucci T, Falasca M (2018) GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine. Oncogene 37:6368\u20136382","journal-title":"Oncogene"},{"key":"7_CR336","doi-asserted-by":"crossref","first-page":"16511","DOI":"10.1073\/pnas.0902743106","volume":"106","author":"LS Whyte","year":"2009","unstructured":"Whyte LS, Ryberg E, Sims NA, Ridge SA, Mackie K, Greasley PJ, Ross RA, Rogers MJ (2009) The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo. Proc Natl Acad Sci U S A 106:16511\u201316516","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR337","doi-asserted-by":"crossref","first-page":"e122947","DOI":"10.1172\/jci.insight.122947","volume":"4","author":"S Korchynska","year":"2019","unstructured":"Korchynska S, Lutz MI, Borok E, Pammer J, Cinquina V, Fedirko N, Irving AJ, Mackie K, Harkany T, Keimpema E (2019) GPR55 controls functional differentiation of self-renewing epithelial progenitors for salivation. JCI Insight 4:e122947","journal-title":"JCI Insight"},{"key":"7_CR338","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076907","volume":"8","author":"S Sisay","year":"2013","unstructured":"Sisay S, Pryce G, Jackson SJ, Tanner C, Ross RA, Michael GJ, Selwood DL, Giovannoni G, Baker D (2013) Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis. PLoS One 8:e76907","journal-title":"PLoS One"},{"key":"7_CR339","doi-asserted-by":"crossref","first-page":"eaao1135","DOI":"10.1126\/sciimmunol.aao1135","volume":"2","author":"H Sumida","year":"2017","unstructured":"Sumida H, Lu E, Chen H, Yang Q, Mackie K, Cyster JG (2017) GPR55 regulates intraepithelial lymphocyte migration dynamics and susceptibility to intestinal damage. Sci Immunol 2:eaao1135","journal-title":"Sci Immunol"},{"key":"7_CR340","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ijo.2015.209","volume":"40","author":"A Meadows","year":"2016","unstructured":"Meadows A, Lee JH, Wu CS, Wei Q, Pradhan G, Yafi M, Lu HC, Sun Y (2016) Deletion of G-protein-coupled receptor 55 promotes obesity by reducing physical activity. Int J Obes (Lond) 40:417\u2013424","journal-title":"Int J Obes (Lond)"},{"key":"7_CR341","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1096\/fj.201800171R","volume":"33","author":"C Lipina","year":"2019","unstructured":"Lipina C, Walsh SK, Mitchell SE, Speakman JR, Wainwright CL, Hundal HS (2019) GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues. FASEB J 33:1299\u20131312","journal-title":"FASEB J"},{"key":"7_CR342","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1111\/bph.14387","volume":"175","author":"JD Hill","year":"2018","unstructured":"Hill JD, Zuluaga-Ramirez V, Gajghate S, Winfield M, Persidsky Y (2018) Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis. Br J Pharmacol 175:3407\u20133421","journal-title":"Br J Pharmacol"},{"key":"7_CR343","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1073\/pnas.1211204110","volume":"110","author":"S Sylantyev","year":"2013","unstructured":"Sylantyev S, Jensen TP, Ross RA, Rusakov DA (2013) Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses. Proc Natl Acad Sci U S A 110:5193\u20135198","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7_CR344","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/hipo.22747","volume":"27","author":"K Hurst","year":"2017","unstructured":"Hurst K, Badgley C, Ellsworth T, Bell S, Friend L, Prince B, Welch J, Cowan Z, Williamson R, Lyon C, Anderson B, Poole B, Christensen M, McNeil M, Call J, Edwards JG (2017) A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity. Hippocampus 27:985\u2013998","journal-title":"Hippocampus"},{"key":"7_CR345","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1523\/ENEURO.0011-15.2015","volume":"2","author":"H Cherif","year":"2015","unstructured":"Cherif H, Argaw A, Cecyre B, Bouchard A, Gagnon J, Javadi P, Desgent S, Mackie K, Bouchard JF (2015) Role of GPR55 during Axon Growth and Target Innervation. eNeuro 2:11\u201315","journal-title":"eNeuro"},{"key":"7_CR346","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/mol.115.099333","volume":"88","author":"E Deliu","year":"2015","unstructured":"Deliu E, Sperow M, Console-Bram L, Carter RL, Tilley DG, Kalamarides DJ, Kirby LG, Brailoiu GC, Brailoiu E, Benamar K, Abood ME (2015) The lysophosphatidylinositol receptor GPR55 modulates pain perception in the periaqueductal gray. Mol Pharmacol 88:265\u2013272","journal-title":"Mol Pharmacol"},{"key":"7_CR347","volume":"8","author":"CS Wu","year":"2013","unstructured":"Wu CS, Chen H, Sun H, Zhu J, Jew CP, Wager-Miller J, Straiker A, Spencer C, Bradshaw H, Mackie K, Lu HC (2013) GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination. PLoS One 8:e60314","journal-title":"PLoS One"},{"key":"7_CR348","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0167965","volume":"11","author":"M Bjursell","year":"2016","unstructured":"Bjursell M, Ryberg E, Wu T, Greasley PJ, Bohlooly YM, Hjorth S (2016) Deletion of Gpr55 results in subtle effects on energy metabolism, motor activity and thermal pain sensation. PLoS One 11:e0167965","journal-title":"PLoS One"}],"container-title":["Advances in Experimental Medicine and Biology","Druggable Lipid Signaling Pathways"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-50621-6_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T08:32:45Z","timestamp":1723537965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-50621-6_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030506209","9783030506216"],"references-count":348,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-50621-6_7","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"8 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}